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Abstract
Multivariate data is common in a wide range of settings. As data structures be-
come increasingly complex, additional statistical tools are required to perform
proper analyses. In this dissertation we develop and evaluate methods for the
analysis of multivariate data generated from cancer trials. In the first chapter we
consider the analysis of clustered survival data that can arise frommulticenter clin-
ical trials. In particular, we review and compare marginal and conditional models
numerically through simulations and discuss model selection techniques. A mul-
ticenter clinical trial of children with acute lymphoblastic leukemia is used to illus-
trate the findings. The second and third chapters both address the setting where
multiple outcomes are collected when the outcome of interest cannot be measured
directly. A head and neck cancer trial in which multiple outcomes were collected
to measure dysphagia was the particular motivation for this part of the disserta-
tion. Specifically, in the second chapter we propose a semiparametric latent vari-
able transformation model that incorporates measurable outcomes of mixed types,
including censored outcomes. This method extends traditional approaches by al-
lowing the relationship between the measurable outcomes and latent variable to
be unspecified, rendering more robust inference. Using this approach we can di-
rectly estimate the treatment (or other covariate) effect on the unobserved latent
variable, enhancing interpretation. In the third chapter, the basic model from the
second chapter is maintained, but additional parametric assumptions are made.
This model still has the advantages of allowing for censored measurable outcomes
iii
and being able to estimate a treatment effect on the latent variable, but has the
added advantage of good performance in a small data set. Together the methods
proposed in the second and third chapters provide a comprehensive approach for
the analysis of complex multiple outcomes data.
iv
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A Comparison of Methods for Analyzing Clustered
Survival Data in Multicenter Clinical Trials
Anna C. Snavely and Yi Li
1.1 Abstract
Clustered survival data often arise from large randomized clinical trials conducted
in multiple centers. There are two major classes of models for addressing clus-
tering in this setting: marginal (population-averaged) models and conditional
(center-specific) models. This paper reviews and compares marginal and condi-
tional models (frailty models in particular) numerically through simulations that
consider the impact of model misspecification on point estimates for both true
marginal models and true frailty models. We show that large differences can exist
between marginal and conditional coefficients, particularly when the within clus-
ter dependence is strong. We also demonstrate that AIC/BIC cannot be used for
model selection.
1.2 Introduction
Many large randomized clinical trials are carried out at multiple medical centers
in order to facilitate the recruitment of a sufficient number of patients. Multicenter
designs also allow for greater generalizability of results. However, additional com-
plications arise with multicenter designs. Different medical centers tend to have
different patient populations, different doctors, and different standard practices.
Because of these center differences, it is likely that patients within the same center
are more similar to each other than to patients in a different center even though
trial-specific protocols are followed. This can lead to dependence, or clustering,
of outcomes from the same center. See, for example, Anello et al. (2005), Fleiss
(1986), Gray (1994), and Senn (1998). Therefore, when doing an analysis of such a
trial, it is important to take this clustering into account. When the effect of cluster-
ing is strong, not accounting for the dependence can lead to misleading inference
(Glidden & Vittinghoff, 2004).
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A common outcome in multicenter clinical trials is survival or some other
failure time. This makes exploring methods for accounting for clustering in time-
to-event data important. This paper reviews some of the available methods for
analyzing such clustered time-to-event data and presents simulation results com-
paring the various methods. In particular, the interest of many randomized tri-
als is assessing a potential treatment effect. However, this treatment effect can
have either a population-averaged interpretation or a conditional interpretation
depending on which method of analysis is used. Therefore, this paper seeks not
only to compare the different methods, but also to explore relationships between
population-averaged and conditional effects and to consider how to choose be-
tween the various models. Simulations investigate varying levels of censoring and
correlation within center, and varying number of clusters. The methods are also
compared using data from a Children’s Oncology Groupmulticenter trial for acute
lymphoblastic leukemia.
1.3 Methods For Analyzing Clustered Failure Time
Data
Suppose censored failure time data is obtained from a multicenter clinical trial
with J clusters (centers) and with nj subjects in cluster j (j = 1, . . . , J). The total
sample size is then N =
P
j nj . Let Tij and Cij be the failure time and censoring
time for subject i in cluster j. We then observe Xij = min(Tij, Cij), the follow-up
time, and  ij = I(Tij < Cij), the failure indicator. Zij is a vector of covariates for
subject i in cluster j. Let Tj be the vector of failure times for cluster j, Cj be the
vector of censoring times for cluster j and Zj be the covariate matrix for cluster
j. Then, we assume that Tj , Cj , and Zj are independent across centers and that
(Tj,Cj) are conditionally independent given Zj .
When dealing with clustered time-to-event data, there are twomajor classes
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of models: marginal (or population-averaged) models (Wei et al., 1989; Lin, 1994;
Prentice & Cai, 1992; Cai & Prentice, 1995) and conditional (center-specific) models
(Murphy, 1994, 1995; Parner, 1998; Vaupel et al., 1979). If we consider a Cox model
with covariate vector Zij , the marginal hazard for subject i in center j is:
 ij(t|Zij) =  0(t)exp( TZij). (1.1)
In this model, the baseline hazard,  0(t), is not specific to a particular center. If
we consider the interpretation of the coefficient ( T ) for a treatment covariate in
this setting (1 indicating treatment and 0 indicating placebo), e T is the marginal
hazard ratio that compares the risk of failure for an individual who receives treat-
ment and an individual who receives placebo who are randomly selected from the
population. This means that marginal models give a population-averaged inter-
pretation for the regression parameters. Both the naive (traditional) Cox model
and the marginal Cox model (takes into account clustering) produce coefficients
with population-averaged interpretations.
On the other hand, if the center is explicitly taken into account when mod-
eling the hazard, we get a conditional model of the form:
 ij(t|Zij) =  0j(t)exp( TZij). (1.2)
Center is included in this model through a center-specific baseline hazard,  0j(t).
In this case, e T is the hazard ratio that compares the risk of failure for an individ-
ual who receives treatment and an individual who receives placebo who are from
the same center. In other words, regression parameters in conditional models must
be interpreted as conditional on the center (Glidden & Vittinghoff, 2004). The fixed
effects Cox model, which is fit by including dummy variables for each center in
the traditional Cox model (Glidden & Vittinghoff, 2004), the stratified Cox model
(Holt & Prentice, 1974), and the frailty model are all examples of conditional mod-
els. Frailty models are particularly useful and will be the only class of conditional
models considered further in this paper.
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Since the  s in model (1.1) and model (1.2) have different interpretations,
in general it is not expected that the values for the two coefficients would be the
same. In fact, the only time we would expect the coefficients to be the same in the
marginal and conditional models is when there is no correlation within the center
(Therneau & Grambsch, 2000).
1.3.1 The Naive Cox Model (A Population-Averaged Model)
The Cox proportional hazards model (Cox, 1972, 1975) is the most popular method
for analyzing failure time data. Model (1.1) represents the form of the Cox model,
where  0(t) is an unspecified non-negative function. Estimation of   is based on
the partial likelihood:
L( ) =
JY
j=1
njY
i=1
"
exp( TZij)PJ
k=1
Pnk
l=1 I(Xkl   Xij)exp( TZkl)
# ij
. (1.3)
The partial likelihood is not a full likelihood, but can be treated as such for the
purpose of inference. This means the estimate of   can be found by solving the
score equation and the inverse information can be used to estimate the variance.
The Cox model assumes that the observations are independent. However, this
assumption does not hold in the case of clustered failure time data. Therefore, if
the naive Cox model is used for clustered time-to-event data, variance estimates
are likely to be too small (Lorino et al., 2004). As such, when your data are truly
clustered the naive Cox model should not be used for analysis.
1.3.2 The Marginal Cox Model (A Population-Averaged Model)
The estimates for the regression parameters in the naive Cox model are fine when
we have clustered failure time data. This means that parameter estimates can still
be obtained using the partial likelihood. However, the variance term needs to be
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corrected in an analogousmanner as is done in the generalized estimating equation
approach of Liang et al. (1992).
One approach to getting a robust variance estimator is by using the grouped
jackknife. This means that the model is fit leaving out one cluster at a time, giving
us jackknife influence values:  ˆ(j)    ˆ. These jackknife influence values can then
be used to estimate the variance (Therneau & Grambsch, 2000).
Another approach is to use an approximation to the jackknife in the form
of a sandwich estimator: ABA. In this estimator, A is the usual variance estimate
and B is a correction term. In our setting the sandwich estimator can be written as
V = I 1(UTU)I 1, where I is the observed information matrix and U is the matrix
of score residuals (Therneau & Grambsch, 2000). Lin & Wei (1989) developed an
appropriate sandwich estimator for the Cox model which is algebraically equiva-
lent to V. They showed this estimate is consistent and robust to several forms of
misspecification.
A final approach is to use a modified sandwich estimator (Therneau &
Grambsch, 2000; Lee et al., 1992). This estimator can be written as V ⇤ =
I 1(U˜T U˜)I 1, where U˜ is the collapsed score matrix obtained by replacing each
cluster of rows in U by the sum of those rows. This is the approach that R and
S-Plus use to get a robust variance estimator (Lorino et al., 2004).
1.3.3 The Frailty Model (A Conditional Model)
The frailty (or random effects) model assumes that center has a proportional effect
on the baseline hazard function, that the center effects come from some probability
distribution and that there is a constant treatment effect across centers. The ran-
dom center effects are continuous variables that describe the excess risk (frailty) for
each center. The frailties account for center heterogeneity caused by unmeasured
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variables (Aalen, 1988). In this formulation we assume that subjects in the same
center have the same excess risk. Therefore, this formulation of a random effects
survival model is often called a shared frailty model. The form of such a frailty
model is:
 ij(t) =  0(t)wjexp( 
TZij) =  0(t)exp( 
TZij +  j). (1.4)
From this formulation we see that model (1.4) is just a special case of model (1.2)
where the frailties (wj) are assumed to act multiplicatively on a common baseline
hazard,  0(t) (Therneau & Grambsch, 2000). Two of the most common distribu-
tions for the wjs are gamma and log normal. The positive stable distribution is
also sometimes used because of nice theoretical properties. An advantage of the
frailty model is that the frailties (center effects) can be estimated. This is useful if
differences between centers are of particular interest.
In the gamma frailty model (Murphy, 1994, 1995; Parner, 1998; Klein, 1992;
Nielsen et al., 1992), wj follows a Gamma(1/✓, 1/✓) distribution. In the log nor-
mal frailty model (McGilchrist & Aisbett, 1991; McGilchrist, 1993) the  js follow
a normal distribution with mean 0 and variance ✓. Since the  js follow a normal
distribution, the frailties (wj) follow a log normal distribution. For both models,
a larger ✓ means the frailties are more dispersed and there is a larger dependence
within centers. Therefore, a larger ✓ leads to greater heterogeneity in the center-
specific baseline hazards. If ✓ is 0, then the frailties are equal to 1, and failures are
independent both within and across centers.
The penalized Cox model is an efficient approach of estimation for the
gamma and log normal frailty models. This method of estimation proceeds by
maximizing the penalized partial log-likelihood:
PPL = l( ,  )  g( ; ✓). (1.5)
The first piece of (1.5) is the usual Cox partial likelihood and the second piece is a
constraint function that penalizes less desirable values of w. The penalty function
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for the gamma frailty model is (1/✓)
P
[ j   exp( j)] and the penalty function for
the log normal frailty model is (1/2✓)
P
 2j .
For both the log normal and gamma frailty models we could consider av-
eraging over the frailty distribution in order to see the effect of covariates on the
marginal hazard. When this is done, it can be seen that both the gamma and the log
normal models lead to non-proportional marginal hazards (Glidden & Vittinghoff,
2004; Lorino et al., 2004). On the other hand, when averaging over the frailty dis-
tribution in the positive stable frailty model (Hougaard, 1986; Fine et al., 2003), the
proportionality of the marginal hazard is maintained. Because the proportionality
is maintained, there is a direct relationship between the conditional and marginal
coefficients. Let   be the coefficient in the positive stable frailty model and let   be
the coefficient in the marginal model. In this case the following relationship holds,
where 0  ↵  1:
  = ↵ . (1.6)
We can see from (1.6) that the conditional parameter from the frailtymodel is larger
in magnitude than the marginal coefficient. Unlike the gamma and log normal
frailty models, the positive stable frailty model cannot be fit using the penalized
Cox model approach. The positive stable model can be fit using the EM algorithm,
but this algorithm is quite slow and proper variance estimates require further com-
putation (Therneau &Grambsch, 2000). A SASmacro by J. P. Klein implements the
EM algorithm for the positive stable model, but no such software is available in S-
Plus/R. Hougaard (2000) also has developed software for fitting the positive stable
model, but it has not been made available to the public. While the positive stable
model has nice theoretical properties, the lack of efficient publicly available soft-
ware makes it less attractive. As such, the positive stable frailty model will not be
considered in the simulation study.
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1.4 Simulation Study
A simulation study was carried out with the aim of comparing and choosing be-
tween the naive Coxmodel, the marginal Coxmodel, the gamma frailty model and
the log normal frailty model. The fourmodels were compared both using data sim-
ulated to follow a proportional hazards model with a known marginal treatment
effect and data simulated to follow a proportional hazards model with a known
conditional treatment effect.
1.4.1 True Model: Marginal Model
In multicenter clinical trials, it is often the case that we are interested in the
population-averaged interpretation of covariates (treatment in particular). This
would suggest the use of the marginal Cox model. In order to evaluate and com-
pare the performance of the naive Cox model and the marginal Cox model, data
were generated to marginally follow a proportional hazards model with a known
treatment effect. Under this simulation setting we consider estimates for the treat-
ment effect ( ), the model-based standard error, the empirical standard error, the
bias, the mean squared error, the empirical coverage of 95 percent confidence in-
tervals, AIC and BIC. We can fit the frailty models to the data as well and calculate
the same quantities. However, because the marginal and conditional treatment
effects are not expected to be the same, the bias (and by extension the MSE) repre-
sents the difference from the true marginal effect, not the difference from the true
conditional effect. These simulations, therefore, do not let us see how well models
estimate the true conditional effect. However, the study is useful to consider rela-
tionships between marginal and conditional coefficients across different settings,
as well as to consider how the conditional coefficients compare to each other across
different settings.
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Method of Simulation
The clustered failure time data with a knownmarginal treatment effect were simu-
lated using a normal transformation model approach (Othus, 2009; Li & Lin, 2006).
If we assume a Cox proportional hazards model (1.1), then the survival function
can be written as:
S(t) = exp( e TZij⇤0(t)). (1.7)
⇤0(t) in (1.7) is the cumulative hazard function. For simplicity we can take  0(t) =
1 and have only a single treatment (Bernoulli) covariate. A transformation and the
probability integral transform can then be used to get T ⇤ij random variables that
follow a standard normal distribution:
T ⇤ij =  
 1(S(Tij)) =   1(exp( e TZijTij)) =
p
 bi + ✏ij (1.8)
Therefore, in order to generate clustered survival times (Tij), we can generate T ⇤ij
by generating bi from a N(0,1) distribution and ✏ij from a N(0,1    ) distribution
and then transforming back.
Twenty-four different simulation settings were considered: 2 levels of cen-
soring (30%, 60%), 4 levels of correlation ( = 0, 0.25, 0.5, 0.75), and 3 levels of
cluster number (30, 60, 90). For each setting, 500 simulations were carried out.
The single treatment covariate was generated from a Bernoulli(0.5) distribution
for each setting to give approximately equal numbers in the treatment and placebo
groups, which mimics many clinical trials. The marginal treatment effect ( ) was
set to log(0.5) = -0.693 for each setting as well. Since we are primarily interested in
the multicenter clinical trial setting, cluster size was randomly generated to allow
clusters of varying size. Cluster size was constrained to be between 10 and 50 with
a mean cluster size of 30, again to mimic the clinical trial setting.
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Results
Table 1.1 presents simulation results for the models with 30% censoring where the
true model is the marginal model and Table 1.2 presents similar results for models
with 60% censoring. We will first focus on the two models with marginal interpre-
tations. The first thing to note is that the estimates for   are the same under both
the naive Cox model and the marginal Cox model, which implies the bias is also
the same for both models. The fact that the estimates are the same is expected be-
cause the parameters in both cases are estimated using the partial likelihood (1.3).
Because the same partial likelihood is used for both models, the AIC and BIC are
also identical for the two models. The difference in the models, therefore, is in
the standard errors. This difference in standard errors becomes greater as the cor-
relation increases since the standard errors under the marginal model increase as
the correlation increases. The naive model performs fairly well when the corre-
lation is small (  = 0.25). However, it is clear that the naive model has standard
errors that are too small when the correlation within center becomes stronger. This
can be seen by the somewhat poor empirical coverage of 95% confidence intervals
for the higher levels of  . For larger correlations, it also appears that while the
marginal model performs much better than the naive model, the marginal model
still tends to somewhat underestimate the standard errors as evidenced by the em-
pirical standard errors being larger than the model-based standard errors.
In all the settings the marginal Cox model performs well. This can be seen
by the small biases and the empirical coverage of the confidence intervals being
close to 95% in all cases. However, the bias does tend to increase as the correla-
tion increases. This pattern is more pronounced when the number of clusters is
smaller. Also, when there is more correlation, the bias is smaller when there are
more clusters. When the censoring is higher, the standard errors for both the naive
Cox model and the marginal model are inflated compared to the corresponding
11
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models with lower censoring. This inflation is not as pronounced when the num-
ber of clusters is higher.
When there is no dependence within center (  = 0), the conditional co-
efficient and the marginal coefficient should be the same. Under this constraint,
the frailty models perform well (small bias) and have similar performance to the
marginal model. When the correlation within center increases, the estimate of the
treatment effect becomes larger in magnitude (becomes more negative). This leads
to a larger difference between the conditional andmarginal coefficients. This result
is expected theoretically (Henderson & Oman, 1999) and can be seen from the re-
lationship between the conditional and marginal parameters in the positive stable
model (1.6). For the frailty models, the empirical coverage of the 95% confidence
intervals tends to decrease with increasing correlation. This may be a consequence
of the standard errors being estimated under the assumption that ✓ is a fixed, rather
than estimated, quantity (Therneau & Grambsch, 2000). It also appears that the
model-based standard errors tend to be too small for larger correlations as seen by
the larger empirical standard errors.
The gamma and log normal frailty models give very similar results for the
estimates of both the treatment effect and the standard errors. This leads to bias
and MSE estimates that are very close. The AIC and BIC are also quite similar
between the two frailty models and are always higher for the population-averaged
models than for the frailty models. As was the case for the population-averaged
models, standard errors are inflated for the settings with higher censoring. The
coefficients also tend to be larger (closer to 0) under the higher censoring settings.
The relationship between the marginal and conditional coefficients can be
seen visually by looking at Figure 1.1, which is representative of the different sim-
ulation settings. When there is no dependence within center, the marginal and
conditional coefficients are quite close. However, as the amount of dependence
14
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Figure 1.1: Plots of absolute relative bias versus   for 60 clusters and 30% censoring where
the true model is the marginal model.
increases, the difference between the conditional and true marginal coefficients in-
creases. In fact, for large amounts of dependence within center, we see that the
difference between the two types of estimates is quite drastic. From the picture, it
is also clear that the gamma and log normal frailty models perform very similarly.
1.4.2 True Model: Conditional Model
In multicenter clinical trials we may also be interested in center effects or a center-
by-treatment interaction. In this case, the use of a frailty model would be rea-
sonable. In order to evaluate and compare the performance of the gamma frailty
model and the log normal frailty model, data were generated to follow a pro-
15
portional hazards model with a known conditional treatment effect. As in the
marginal setting, we consider estimates for the treatment effect ( ), the model-
based standard error, the empirical standard error, the bias, the mean squared er-
ror, the empirical coverage of 95 percent confidence intervals, AIC and BIC. We
can fit the population-averaged models to the data as well but the bias (and by
extension the MSE) represents the difference from the true conditional effect, not
the difference from the true marginal effect. These simulations, therefore, do not
let us see how well models estimate the true marginal effect. The simulations do,
however, allow us to consider relationships between marginal and conditional co-
efficients across different settings.
Method of Simulation
The clustered failure time data with a known conditional treatment effect were
simulated using the approach of Bender et al. (2005), with the addition of a frailty
term. Exponential clustered survival times (Tij) can be simulated using the follow-
ing equation:
Tij =   log(Uij)
 exp( TZij +  j)
(1.9)
where Uij is generated from a Uniform(0,1) distribution and   is the scale parame-
ter for the exponential distribution (chosen to be 2 for our simulations).  j in (1.9)
is the frailty term (shared by all patients in the same center) that controls the de-
pendence within each cluster. For our simulations, the  js were generated either
from the log of a Gamma (1/✓, 1/✓) distribution (true model: gamma frailty model)
or from a Normal(0, ✓) distribution (true model: log normal frailty model).
As in the marginal setting, twenty-four different simulation settings were
considered for both the gamma frailty and log normal frailty settings: 2 levels of
censoring (30%, 60%), 4 levels of dependence within center (✓= 0, 0.67, 2, 6), and 3
levels of cluster number (30, 60, 90). The values of ✓ (variance of the frailty term)
16
were chosen to correspond to Kendall’s ⌧ values of 0, 0.25, 0.5, and 0.75 under the
gamma frailty model. For each setting, 500 simulations were carried out and a
single treatment covariate was generated from a Bernoulli(0.5) distribution. The
conditional treatment effect ( ) was set to log(0.5) = -0.693 for each setting and
cluster size was randomly generated to allow clusters of varying sizes between 10
and 50 with a mean cluster size of 30.
Results
Table 1.3 presents simulation results for the models with 30% censoring where the
true model is the gamma frailty model and Table 1.4 presents similar results for
models with 60% censoring. We will first focus on the performance of the two
frailty models. There are small biases and the empirical coverage of the confidence
intervals are close to 95% in all cases, suggesting that the gamma frailty model
performs well in all the settings. This is to be expected since the true frailty is from
a gamma distribution. However, the log normal frailty model also performs very
well and even outperforms the gamma frailty model in some cases (smaller bias).
For both models, when the number of clusters is smaller, there is some tendency
for the frailty model to underestimate the standard errors, particularly with higher
correlation within center. Higher censoring has the effect of increasing the stan-
dard errors. When there is dependence within center (✓ > 0), the AIC and BIC do
tend to be lower for the gamma frailty model as compared to the log normal frailty
model. This difference is most apparent for the higher correlations. When there is
no dependence within center (✓ = 0), the AIC and BIC are lower for the log normal
frailty model than the gamma frailty model.
When there is no dependence within center (✓ = 0), the conditional coef-
ficient and the marginal coefficient should be the same. In this setting, both the
naive Cox model and the marginal Cox model perform similarly to the frailty
17
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model. However, when the correlation within center increases, the estimate of
the treatment effect for the population-averaged models becomes smaller in mag-
nitude (becomes less negative). This leads to a larger difference between the con-
ditional and marginal coefficients. As expected, the bias is the same for the naive
Cox model and the marginal Cox model. Interestingly, however, the standard er-
ror estimates are similar for the two models as well. This suggests that when the
true model is a gamma frailty model, performance does not differ much between
the naive Cox and marginal Cox models even though dependence within center is
present. AIC and BIC are always higher for the population-averaged models than
for the frailty models.
Table 1.5 presents simulation results for the models with 30% censoring
where the true model is the log normal frailty model and Table 1.6 presents similar
results for models with 60% censoring. When the true model is the log normal
frailty model, the log normal frailty model performs well in all settings as seen by
small biases and empirical coverage of confidence intervals that are close to 95%.
The gamma frailty model also performs very well and again even outperforms
the log normal frailty model in some cases (smaller bias). As in the gamma case,
when the number of clusters is smaller, there is some tendency for the frailty model
to underestimate the standard errors, particularly with higher correlation within
center and higher censoring has the effect of increasing the standard errors. When
there is dependence within center (✓ > 0), the AIC and BIC tend to be very similar
for the two frailty models. Even though the true model is the log normal frailty
model, in many of the settings, the AIC and BIC are lower for the gamma frailty
model.
When there is no dependence within center (✓ = 0), the naive Cox model
and the marginal Cox model again perform similarly to the frailty models. When
the correlation within center increases, results are similar as in the gamma case.
The estimate of the treatment effect for the population-averaged models becomes
20
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Figure 1.2: Plots of absolute relative bias versus ✓ for 60 clusters and 30% censoring where
the true model is a conditional model.
smaller in magnitude (becomes less negative). Results suggest that when the true
model is a log normal frailty model, performance does not differ much between
the naive Cox and marginal Cox models even though dependence within center is
present.
The relationship between the marginal and conditional coefficients can be
seen visually by looking at Figure 1.2. When there is no dependence within center,
the marginal and conditional coefficients are quite close. However, as the amount
of dependence increases, the difference between the marginal and true conditional
coefficient increases. The pattern of the absolute relative bias is similar for both the
true gammamodel and the true log normal model. However, the bias is somewhat
smaller in the case of the log normal frailty model. From the picture, it is also clear
that the gamma and log normal frailty models perform very similarly.
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1.5 Data Example
The Children’s Oncology Group (COG) study 1961 was used to study postinduc-
tion intensification (PII) in children and adolescents with“higher risk” acute lym-
phoblastic leukemia (ALL) (Seibel et al., 2008). The goal of the study was to see
if longer duration PII and increased strength PII would improve the survival for
children with“higher risk” ALL and a rapid marrow response to induction ther-
apy. In order to ascertain the relative benefit or harm of each variation of PII, a 2X2
factorial design was used. For the purpose of this analysis two patient populations
were studied: the full sample of 1299 patients, and a subset of 460 patients with
enlarged livers, which represents a subgroup of sicker patients. The endpoint of
interest in this case is overall survival.
The four methods focused on in the paper were applied to both the full
dataset and the enlarged liver subset. There was no evidence of a duration by
strength interaction in either case. Therefore, the various models include the
two treatment variables, increased strength and duration, and three other base-
line characteristics: gender, age, and platelet count at diagnosis. Using the full
dataset, very little clustering is seen as evidenced by the Kendall’s ⌧ estimate from
the gamma frailty model of < 0.001 (95% CI: (-0.015, 0.015)). On the other hand,
there is a suggestion of a clustering effect for the enlarged liver subset as seen by
the Kendall’s ⌧ estimate of 0.192 for the gamma frailty model. However, the 95%
confidence interval of (-0.110, 0.494) suggests this effect might not be significant.
95% confidence intervals for Kendall’s ⌧ were calculated using the jackknife leav-
ing out one cluster at a time. Table 1.7 presents data analysis results for the full
dataset and Table 1.8 presents results for the enlarged liver subset.
In the full dataset, we can see that there is a significant effect of increased
strength, but a quite insignificant effect of increased duration. Results in this case
suggest that increased strength is associatedwith improved survival for the overall
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Table 1.7: COG data analysis results - full dataset
Parameter Estimate SE p-value
Naive Cox
Increased Strength -0.436 0.150 0.004
Increased Duration -0.108 0.147 0.460
AIC = 2594.4; BIC = 2630.6
Marginal Cox
Increased Strength -0.436 0.141 0.002
Increased Duration -0.108 0.145 0.456
AIC = 2594.4; BIC = 2630.6
Gamma Frailty
Increased Strength -0.436 0.150 0.004
Increased Duration -0.108 0.147 0.460
AIC = 2596.4; BIC = 2637.7
Log Normal Frailty
Increased Strength -0.438 0.150 0.003
Increased Duration -0.107 0.147 0.470
AIC = 2592.7.4; BIC = 2634.0
*Models also include gender, age, and platelet count at diagnosis
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Table 1.8: COG data analysis results - enlarged liver subset
Parameter Estimate SE p-value
Naive Cox
Increased Strength -0.429 0.247 0.082
Increased Duration 0.409 0.250 0.102
AIC = 809.7; BIC = 838.6
Marginal Cox
Increased Strength -0.429 0.229 0.061
Increased Duration 0.409 0.242 0.091
AIC = 809.7; BIC = 838.6
Gamma Frailty
Increased Strength -0.466 0.253 0.065
Increased Duration 0.476 0.257 0.064
AIC = 764.5; BIC = 797.5
Log Normal Frailty
Increased Strength -0.462 0.253 0.067
Increased Duration 0.488 0.257 0.057
AIC = 763.6; BIC = 796.7
*Models also include gender, age, and platelet count at diagnosis
26
study population. Also of particular interest in this case is the similarity between
the coefficient estimates for all of the models. Even though some of the parameters
have conditional interpretations and others have marginal interpretations, in this
case there is very little difference between them. This is to be expected, however,
since the amount of dependence is so small. We also note that the gamma and
log normal frailty models give almost identical results, suggesting that the choice
of frailty is not crucial. In this setting we would recommend using the traditional
Cox model for analysis since clustering within center is not an issue.
In the enlarged liver subset, we see that there is a marginally significant ef-
fect of both increased strength and increased duration for most of the models. Re-
sults suggest that increased strength is associated with improved survival and that
increased duration is associated with worse survival. Unlike the full dataset, in
this subset, there are differences between the marginal and conditional coefficient
estimates. We can see that the marginal estimates are closer to 0 than the condi-
tional estimates. This illustrates that even with a minimal amount of dependence
in the dataset, the differences between marginal and conditional coefficients are
apparent. In this subset, we would recommend using the marginal Cox model for
analysis since there is some evidence of clustering within center and since the aim
of the trial is to determine the effectiveness of treatment at the population level.
1.6 Discussion
This paper has reviewed current methods for dealing with clustered failure time
data that may arise from multicenter clinical trials. The simulation study has
shown that when your data are clustered and marginally follow a proportional
hazards model, the marginal Cox model is readily able to estimate a population-
averaged treatment effect in a variety of settings. The naive Cox model does a rea-
sonable job when the within cluster dependence is small, but should not be used
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when the clustering effect is more significant. When your data are clustered and
follow a proportional hazards model with a frailty term, both the gamma frailty
model and the log normal frailty model do a good job of estimating the condi-
tional treatment effect in a variety of settings. Both models perform well whether
the true frailty is gamma or log normal.
The population-averaged models perform well when the true model is a
marginal model and the frailty models perform well when the true model is a
conditional model. However, when a marginal model is fit to a true conditional
model or a frailty model is fit to a true marginal model, large differences in the
coefficients can exist. When the correlation within center is small, there is not a
big difference between the marginal and conditional coefficients. A large amount
of dependence within center, however, means a large difference between the two
types of coefficients. This implies that a correct interpretation of the chosen model
is crucial.
Because the interpretation does differ between the frailty models and the
naive Cox and marginal Cox models, it would be ideal if there was some way of
using the data to perform model selection. Choosing the model with the lowest
AIC or BIC would be a logical choice for doing this model selection. However,
it turns out that this is not a good approach. The AIC and BIC are identical for
the naive Cox and marginal Cox models because they are both based on the same
partial likelihood. This means that AIC or BIC cannot be used to choose between
these two models. The marginal model takes clustering into account in calculating
the standard error. However, the marginal model does not adjust the likelihood in
any way, so the AIC/BIC for the marginal Cox model does not account for clus-
tering. On the other hand, the likelihoods for the frailty models do account for
clustering. Therefore, as the simulations show, the AIC/BIC for the frailty models
is smaller than the AIC/BIC for the marginal Coxmodel even when the true model
is a marginal model and the frailty model leads to biased estimates. This means
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that using AIC or BIC is not a reliable way to choose between a frailty model and
the marginal Cox model when dependence exists within center. It may be possible
to use AIC or BIC to choose between frailty models. However, even this seems
somewhat unreliable since in some simulation settings the AIC/BIC was smaller
for the gamma model than the log normal model even when the true model was
the log normal frailty model.
A possible alternative for model selection would be the use of some testing
procedures. For example, a rejection of the proportional hazards assumption could
be seen as evidence in favor of most frailty models (except for the positive stable
frailty model). However, tests for proportional hazards often have limited power
(Lin &Wei, 1991; Grambsch & Therneau, 1994), especially when the sample size for
a study is moderate. In addition, non-proportionality could be due to an incorrect
functional form of a covariate or missing covariates (Therneau & Grambsch, 2000).
Score tests such as the ones proposed by Gray (1995) and Commenges & Andersen
(1995) could also be an option, but it is unclear that these tests would help with
choosing between the marginal Cox model and a frailty model when clustering
truly exists. Due to the uncertainty of what conclusions can be reliably drawn
from such tests, we opt not to consider testing here for model selection.
Since AIC and BIC are not useful for model selection and testing proce-
dures may not be reliable, there need to be some guidelines about how to choose
between the models. We recommend choosing between marginal and conditional
models based on the scientific question of interest. A marginal model should be
used when the investigator wants to interpret coefficients at the population level
and a conditional model should be used when the center is of greater interest. If a
population-averaged interpretation is of interest and there is clustering within cen-
ter, themarginal Coxmodel should be used. In practice, if correlationwithin center
is even suspected, the marginal Cox model is the best choice. If there is not clus-
tering within center, the traditional Cox model is appropriate. If a center-specific
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interpretation is of interest, either the gamma or log normal frailty models can be
used. The simulation study results suggest that the gamma and log normal frailty
models give very similar results in a variety of settings. The gamma frailty model
may be preferred in practice since there is a straight-forward relationship between
✓ and Kendall’s ⌧ . Being able to calculate Kendall’s ⌧ easily is useful because it is
a statistic that is familiar to a wide range of researchers. However, if these models
are going to be used in practice, it would be useful to have some form of model di-
agnostic to assess the form of the frailty distribution. Some work has been done in
this area for parametric models and bivariate models (Shih & Louis, 1995; Oakes,
1989; Duchateau & Janssen, 2008). However, more work needs to be done in this
area for semiparametric and multivariate models.
This paper has highlighted the fact that there are different interpretations
for marginal and conditional coefficients and that large differences can exist be-
tween these two types of coefficients when within center dependence is strong.
There is not a good way to perform model selection in this setting as AIC and BIC
are not useful, so we offer guidelines that can be used in practice.
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Semiparametric Latent Variable Transformation
Models for Multiple Outcomes of Mixed Types
Anna C. Snavely, David Harrington, and Yi Li
2.1 Abstract
Multiple outcomes are often collected in applications where the quantity of interest
cannot be measured directly, or is difficult or expensive to measure. Latent vari-
able models are commonly adopted in this setting. These models stipulate that
the multiple outcomes are conditionally independent measures of the latent factor,
possibly capturing various aspects of it. Mixed types of outcomes (e.g. continu-
ous vs discrete) and censored outcomes present statistical challenges, however, as
a natural multivariate distribution of mixed data does not exist. In this paper we
propose a new class of semiparametric latent variable models that allows for the
estimation of the latent factor in the presence of measurable outcomes of mixed
types, including censored outcomes. Compared to the existing methods, our pro-
posed model provides the following advantages. First, the model allows the rela-
tionship between the measurable outcomes and latent variable to be unspecified,
rendering more robust inference. Second, the proposed model can directly esti-
mate the treatment (or other covariate) effect on the unobserved latent variable,
greatly enhancing the interpretability of the model. Extensive simulations verify
the utility of the methods. We also apply the method to a clinical trial conducted
by Dana-Farber Cancer Institute, where the focus was to study the effect of treat-
ment on unobservable dysphagia through collected multiple outcomes, which are
of mixed types and one of which is subject to censoring.
2.2 Introduction
Multiple outcomes are often collected in applications where the quantity of inter-
est cannot be measured directly, or is difficult or expensive to measure (Dunson,
2006). Latent variable models are commonly adopted in this setting. These mod-
els stipulate that the multiple outcomes are conditionally independent measures
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of the latent factor, possibly capturing various aspects of it. Mixed types of out-
comes (e.g. continuous vs discrete) are common (Pocock et al., 1987) as are cen-
sored outcomes. These varying outcome types present statistical challenges as a
natural multivariate distribution of mixed data does not exist. For example, in a
head and neck cancer (HNC) trial conducted at Dana-Farber Cancer Institute, the
investigators wanted to determine the effect of clinical and treatment factors on
dysphagia (or difficulty in swallowing) (Chapuy et al., 2011). However, dysphagia
was not directly measurable. Instead, three surrogate outcome measures: dura-
tion of feeding tube usage, weight loss after treatment, and diet (liquid, soft, etc)
were collected. Among them, the first outcome was subject to censoring, while the
other two outcomes are of mixed types; weight loss was measured on a continuous
scale, while the diet was measured on an ordinal scale. Limited statistical tools for
accommodating such complicated data have greatly hampered proper analyses.
When the measurable outcomes are all continuous, the methods are rela-
tively well developed within the latent variable paradigm (Sammel & Ryan, 1996;
Roy & Lin, 2000). Some methods also exist in the context of latent variable model-
ing when the outcomes are of mixed types. For example, Catalano & Ryan (1992),
Fitzmaurice & Laird (1995), Sammel et al. (1997), Regan & Catalano (1999), Mous-
taki & Knott (2000), and Huber et al. (2004) all consider this setting. However,
a limitation of these latent variable models for mixed outcomes is that the rela-
tionship between the measurable outcomes and the Gaussian latent variable must
be known a priori. Since the latent variable is not observed, there is little guid-
ance for the appropriate relationship. If the relationship is misspecified, using the
common likelihood approaches leads to biased estimates for the parameters. Also,
these methods do not allow for survival or event time outcomes where censoring
is present.
In view of all these limitations, we propose a new class of semiparametric
latent variable models that allows for the estimation of the latent factor in the pres-
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ence of mixed outcomes as well as censored outcomes. Compared to the existing
methods, our proposedmodel provides the following advantages. First, the model
allows the relationship between the measurable outcomes and latent variable to be
unspecified, rendering more robust inference. Second, the proposed model can di-
rectly estimate the treatment (or other covariate) effect on the unobserved latent
variable, greatly enhancing the interpretability of the model.
The remainder of the article is organized as follows. Section 2.3 describes
the model and Section 2.4 discusses the estimation and inference procedures. Sec-
tion 2.5 presents simulation results and applies the methodology to analyze the
aforementioned HNC data. We conclude with a discussion in Section 2.6.
2.3 Semiparametric Latent Variable Transformation
Models
Suppose there are n subjects, each with p distinct measurable outcomes. For sim-
plicity, we will focus on the setting where there is a single outcome that is subject
to censoring, though the extension to accommodate multiple censored outcomes
is rather straightforward. Without loss of generality we assume that the first mea-
surable outcome is a continuous event time, denoted by T , which can be censored
by a competing censoring variable, denoted by C. We further assume that T and C
are independent and that C is independent of the covariates. Let Yi1 = min(Ti, Ci)
and  i = I(Yi1 = Ti), where I(·) is the indicator function. Then, for each indi-
vidual i, we observe vectors of covariates Xi1, · · · , Xip (e.g. age and gender) and
Zi (e.g. treatment), a failure indicator  i, and a vector of measurable outcomes
Yi = (Yi1, · · · , Yip)T . The elements of Yi are ordered such that the first p1 elements
are continuous (with the first element being the event time), and the remaining
p2 = p  p1 elements are discrete (including, for example, binary, ordinal, or count
outcomes).
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In order to facilitate joint modeling, the discrete measurable outcomes are
linked to underlying continuous variables as in Muthe´n (1984) and Dunson (2006).
Specifically, let Y uij be a continuous variable underlying Yij . Then, for the discrete
outcomes, for Yij 2 {1, · · · , dj}, we have Yij =
Pdj
l=1 lI(cj(l 1) < Y uij  cj(l))where
dj is the number of categories for the jth outcome and cj = (cj(0), · · · , cj(dj))T
are unknown thresholds satisfying  1 = cj(0) < · · · < cj(dj) = 1. For the
measurable outcomes that are already continuous, Yij = Y uij .
Given the above notation, we can now relate the continuous or underly-
ing continuous outcomes to the latent variable (ei) of primary interest through a
semiparametric linear transformation model:
H1(Ti) = X
T
i1 1 + ↵1ei + "i1,
H2(Y
u
i2) = X
T
i2 2 + ↵2ei + "i2, (2.1)
...
Hp(Y
u
ip) = X
T
ip p + ↵pei + "ip.
H1 is an unknown non-decreasing transformation function such that H(0) =  1
andH2, · · · , Hp are unknown non-decreasing transformation functions that satisfy
Hj( 1) =  1 and Hj(1) = 1 for j = 2, · · · , p.   = ( T1 , · · · ,  Tp )T is a vector of
regression coefficients, ↵ = (↵1, · · · ,↵p)T are factor loadings, ei is a latent variable
for subject i, and "i = ("i1, · · · , "ip)T is a vector of independent errors distributed
as N(0, diag( 21, · · · ,  2p)).
Furthermore, additional structure for the latent variable is assumed:
ei = Z
T
i   + ✏i, (2.2)
where Zi records treatment or other covariates,   is a vector of unknown regression
coefficients, and ✏i is the random error distributed as N(0,  2e). In most instances,  
is the primary parameter for inference since it relates covariates of interest, such as
treatment, to the latent variable (outcome of interest). We assume that Zi and ✏i are
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independent and that for identifiability, Zi and Xij do not contain constant terms,
 2e = 1, and  2j = 1 for j = 1, · · · , p. One of the factor loadings is also constrained
to be positive (Dunson, 2003). Though related, our model is different from the
ordinary random effect models. Random effects are mainly introduced to describe
the unobserved heterogeneity and are usually covariate-independent, whereas the
latent variable, ei, represents specific traits measured by covariates and hence are
covariate-dependent.
2.4 Estimation and Inference Procedures
2.4.1 Likelihood and Estimating Equations
For each given yj 2 {1, · · · , dj} for j = p1 + 1, · · · , p (the discrete measurable
outcomes), let H˜j(yj) = Hj(cj(yj)), where cj is the unknown upper limit of Y uij
when Yij = yj . Because both Hj and Y uij are unknown, they cannot be identified
separately. However, Hj(cj(1)), · · · , Hj(cj(dj   1)) provide the distribution of the
observed outcome Yij and can be estimated. In other words, for the discrete mea-
surable outcomes, estimation of the transformation means estimation of the un-
known transformed thresholds. Also, let H˜j = Hj for the continuous measurable
outcomes (for ease of notation),⇥ = ( ,↵,  ), and H˜ = (H˜1, · · · , H˜p).
Since the error terms in models (2.1) and (2.2) are assumed to be normally
distributed, the vector of transformed continuous outcomes follows a multivariate
normal distribution. The likelihood is not simply a multivariate normal density,
however, because not all of the outcomes are completely observed. More specifi-
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cally, the likelihood can be expressed as:
L(⇥; H˜) / |⌃22|n/2
nY
i=1
Z
x[2]2H[2]i
exp
24 1
2
  
H˜[1]i
x[2]
!
 Xi    ↵ TZi
!T
⌃ 122
  
H˜[1]i
x[2]
!
 Xi    ↵ TZi
!35 dx[2], (2.3)
where Xi = diag(XTi1, · · · , XTip), H˜[1]i = (H˜1(Y ui1), · · · , H˜p1(Y uip1))T , H˜[2]i =
(H˜p1+1(Y
u
i,p1+1), · · · , H˜p(Y uip))T , and H[2]i =
Qp
j=p1+1
[H˜j(Yij), H˜j(Yij + 1)]. This
likelihood arises from the fact that based on models (2.1) and (2.2), H˜i ⌘
(H˜[1]
T
i , H˜
[2]T
i )
T ⇠ N(Xi  + ↵ TZi,⌃22), where ⌃22 = ↵↵T + Ipxp. Here H˜[1]i is com-
pletely observed (as long as the event time is not censored), whereas H˜[2]i is only
known to fall in H[2]i . In the case of a censored event time, the event time can be
incorporated in H˜[2]i . The bounds of integration for the event time ( [H˜1(Yi1),1])
can be included inH[2]i (since now the time is not completely observed).
The likelihood (specifically the conditional likelihood on H˜) in equation
(2.3) involves the unknown transformation functions, so we need a way to esti-
mate these transformations. Following the usual counting process notation, let
Yi(t) = I(Yi1   t) and Ni(t) =  iI(Yi1  t). Then H˜1 for the event time outcome
can be estimated using the following equation (Chen et al., 2002):
nX
i=1
h
dNi(t)  Yi(t)d⇤{H˜1(t) XTi1 1   ↵1ZTi  }
i
= 0 (t   0), (2.4)
where ⇤ is the cumulative hazard function for the transformed event time (i.e. the
cumulative hazard for N(0,↵21 + 1)). For computational purposes, the following
simpler (but asymptotically equivalent) estimating equations can be used:0BBBBB@
1 Pni=1 Yi(t1)⇤{H˜1(t1) Xi    ↵ TZi}
1 Pni=1 Yi(t2) {H˜1(t2 ) Xi    ↵ TZi} H˜1(t2)
...
1 Pni=1 Yi(tK) {H˜1(tK ) Xi    ↵ TZi} H˜1(tK)
1CCCCCA =
0BBBBB@
0
0
...
0
1CCCCCA (2.5)
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where  H˜1(t) = H˜1(t)   H˜1(t ) and K is the number of observed events. The
resulting estimate of H˜1(·) will be a non-decreasing step function that jumps only
at the K observed event times.
H˜j(yj) for j = 2, · · · , p can be estimated using the following equations:
nX
i=1
24I(Yij  yj)   
0@H˜j(yj)  (XTij j + ↵jZTi  )q
↵2j + 1
1A35 = 0 (2.6)
where   is the standard normal cumulative distribution function.
The estimator ˆ˜Hj(·) of H˜j(·) is a non-decreasing step function with jumps
only at the observed Yij for the continuous measurable outcomes. For the discrete
measurable outcomes, the transformed thresholds are estimated through (2.6).
Thus, we have effectively reduced the problem of solving the infinite dimensional
system of equations defined by (2.5) and (2.6) to that of solving a finite system of
equations.
2.4.2 Estimation Algorithm
We propose a procedure that is similar to a profile likelihood to draw inference.
Specifically, given ⇥, the finite dimensional parameters, we use (2.5) and (2.6) to
estimate H˜j(·) for j = 1, · · · , p denoted by H˜(⇥). We then proceed to estimate ⇥
by maximizing a pseudo-likelihood which is the likelihood function L(⇥, H˜(⇥)).
For implementation, we propose the following iterative steps:
Step 1: Choose initial values for  , ↵, and  . Denote these estimates by  ˆ(0), ↵ˆ(0),
and  ˆ(0). Using an initial estimate of 1 for each of the parameters works well
in practice. Picking initial values of 0 for all of the parameters does not work
well.
Step 2: Use the estimating equations (2.5) and (2.6) with  , ↵, and   set equal to
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 ˆ(0), ↵ˆ(0), and  ˆ(0) to obtain initial estimates of the transformation functions,
ˆ˜H(0)j (·).
Suppose that we have estimates of  , ↵,  , and H˜j(·) from the (m  1)th
iteration; denote these estimates by  ˆ(m 1), ↵ˆ(m 1),  ˆ(m 1), and ˆ˜H(m 1)j (·).
Step 3: Maximize the likelihood (2.3) with respect to  , ↵, and  , replacing H˜j(·)
with ˆ˜H(m 1)j (·), to obtain new estimates:  ˆ(m), ↵ˆ(m), and  ˆ(m). We used the
Broyden-Fletcher-Goldfarb-Shanno (BFGS) method for maximization in this
setting. This is a quasi-Newton method that often performs well for opti-
mization problems (Press et al., 1992).
Step 4: Use the estimating equations (2.5) and (2.6) with  , ↵, and   set equal to
 ˆ(m), ↵ˆ(m), and  ˆ(m) to obtain new estimates of the transformation functions,
ˆ˜H(m)j (·).
Step 5: Repeat Steps 3 and 4 until predetermined convergence criteria are met.
2.4.3 Bootstrap
To conduct inference on the parameters, standard error estimates are needed. We
cannot, however, use the standard error estimates that arise from the likelihood
(2.3) as valid estimators of the standard errors for the  , ↵, and   parameters. The
likelihood estimates do not account for the additional variability that comes from
estimating the transformation functions. Instead, we must rely on a resampling
procedure to estimate standard errors for the parameters. In the simulations and
data analysis we have relied on the traditional nonparametric bootstrap where
sampling is done with replacement (Efron & Tibshirani, 1993).
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2.5 Numerical Studies
2.5.1 Simulations
We evaluated the performance of the proposed method through simulations. In
order to mimic the motivating HNC data, we incorporated three measurable out-
comes: an event time outcome, a continuous outcome, and an ordinal outcome
with 5 categories. The following model was assumed for the simulations with
H1 = log and H2 = H3 = Identity:
H1(Ti) = Xi 1 + ↵1ei + "i1,
H2(Yi2) = Xi 2 + ↵2ei + "i2, (2.7)
H3(Y
u
i3) = Xi 3 + ↵3ei + "i3,
and
ei = Zi  + ✏i. (2.8)
Specifically, the underlying continuous variables were generated from the multi-
variate normal distribution,N(Xi +↵ Zi,⌃22), where ⌃22 = ↵↵T +I3⇥3. This way
the measurable outcomes are correlated, and this correlation is determined by the
↵ parameters. The event time outcome was then created through an anti-log trans-
formation. Censoring was introduced through an exponential random variable,
with the parameter for the exponential distribution chosen to given a particular
percentage of censoring. The continuous variable did not require further transfor-
mation and the ordinal outcome was obtained by using the underlying continuous
variable arising from the multivariate normal model and then applying the follow-
ing thresholds: (-1, -1, 0, 1, 2,1). We assumed that there was a single continuous
X covariate common to all threemeasurable outcomes and a single binary Z covari-
ate to represent treatment or some other binary covariate of interest. Specifically,
Xi ⇠ N(0, 1) and Zi ⇠ Bernoulli(0.50). True parameter values were selected to be
 1 = 0.5,  2 = 0.9,  3 = 0.75, ↵1 = 0.5, ↵2 = 0.9, ↵3 = 0.75,   = 1.
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Six different simulation settings were considered. For each setting, 250 sim-
ulations were carried out. Two different sample sizes were explored: n = 100 and n
= 200, and three different censoring levels were considered: 0%, 7%, and 17%. The
7% was chosen to mimic the HNC data. Results for n = 100 can be found in Table
2.1 and results for n = 200 are presented in Table 2.2. We discovered through these
simulations that there is some numerical instability in the estimation procedure.
Convergence of the algorithm is sensitive to the particular data set that you are an-
alyzing. Non-convergence is a definite problem for smaller sample sizes and also
for larger amounts of censoring. The percentage of simulations that did not con-
verge for each simulation setting is presented in Table 2.3. The results presented in
Table 2.1 and 2.2 and Figure 2.1 and 2.2 are, therefore, conditional on convergence.
Sample size is an important factor in the performance of the proposed
method. Figure 2.1 visually compares simulation results for n = 100 and n = 200,
both with 7% censoring (since this is the most relevant case for the HNC data).
From this figure we can see that the point estimates are not right at the truth for all
of the parameters. For example, there does appear to be some underestimation for
the parameters associated with the continuous outcome (↵2 and  2). Despite this
fact, none of the parameters are significantly biased since the empirical confidence
intervals do not exclude the truth. Also, point estimation can be improved by in-
creasing the sample size. For both sample sizes included in the simulations, the
point estimate for the   parameter is well estimated. This is important because this
is the primary parameter for inference since it relates the Z covariate to the latent
variable. Inference, however, may be somewhat unreliable for a sample as small
as 100. For example, numerical instability of the estimation procedure is more of a
problemwith a small sample size (21.7% of simulations failed to converge) and the
95% coverage probabilities based on the bootstrap standard errors tend to deviate
somewhat from the nominal level. In particular, even though the point estimate
for   seems reasonable for n = 100, the bootstrap standard error is somewhat over-
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Table 2.1: Simulation results for n = 100
 1  2  3 ↵1 ↵2 ↵3  
0% Censoring
Mean 0.476 0.713 0.752 0.450 0.576 0.746 1.134
Bias -0.024 -0.187 0.002 -0.050 -0.324 -0.004 0.134
Empirical SE 0.128 0.117 0.156 0.220 0.183 0.234 0.349
Bootstrap SE 0.125 0.139 0.162 0.200 0.203 0.203 0.363
95% CI Coverage 0.935 0.970 0.959 0.858 0.935 0.911 0.976
7% Censoring
Mean 0.519 0.666 0.682 0.622 0.525 0.574 0.979
Bias 0.019 -0.234 -0.068 0.122 -0.375 -0.176 -0.021
Empirical SE 0.187 0.150 0.162 0.381 0.234 0.256 0.316
Bootstrap SE 0.152 0.151 0.164 0.289 0.210 0.226 0.411
95% CI Coverage 0.938 0.928 0.959 0.851 0.877 0.892 0.995
17% Censoring
Mean 0.845 0.570 0.603 1.889 0.504 0.332 0.522
Bias 0.345 -0.330 -0.147 1.389 -0.396 -0.418 -0.478
Empirical SE 0.529 0.179 0.137 1.502 0.174 0.148 0.428
Bootstrap SE 0.274 0.173 0.146 0.712 0.178 0.173 0.446
95% CI Coverage 0.810 0.946 0.958 0.744 0.958 0.976 0.952
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Table 2.2: Simulation results for n = 200
 1  2  3 ↵1 ↵2 ↵3  
0% Censoring
Mean 0.492 0.770 0.773 0.492 0.683 0.759 1.083
Bias -0.008 -0.130 0.023 -0.008 -0.217 0.009 0.083
Empirical SE 0.090 0.092 0.128 0.140 0.116 0.171 0.238
Bootstrap SE 0.088 0.107 0.123 0.152 0.151 0.164 0.250
95% CI Coverage 0.942 0.971 0.947 0.938 0.988 0.951 0.959
7% Censoring
Mean 0.524 0.730 0.694 0.650 0.609 0.595 1.007
Bias 0.024 -0.170 -0.056 0.150 -0.291 -0.155 0.007
Empirical SE 0.120 0.112 0.111 0.324 0.181 0.187 0.294
Bootstrap SE 0.106 0.119 0.118 0.231 0.171 0.176 0.276
95% CI Coverage 0.915 0.969 0.964 0.906 0.924 0.942 0.920
17% Censoring
Mean 0.987 0.599 0.599 2.180 0.534 0.350 0.478
Bias 0.487 -0.301 -0.151 1.680 -0.366 -0.400 -0.522
Empirical SE 0.536 0.143 0.092 1.499 0.167 0.140 0.301
Bootstrap SE 0.260 0.139 0.100 0.708 0.156 0.139 0.323
95% CI Coverage 0.947 0.965 0.941 0.971 0.935 0.900 0.953
Table 2.3: Percentage of simulations that failed to converge
0% Censoring 7% Censoring 17% Censoring
n = 100 32.4 21.7 31.7
n = 200 2.8 10.4 31.7
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Figure 2.1: Plots of means and empirical 95% confidence intervals from simulations with
n = 100 and n = 200 with 7% censoring.
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Figure 2.2: Plots of means and empirical 95% confidence intervals from simulations with
n = 200 and 0%, 7%, and 17% censoring.
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estimated, leading to a coverage probability that is too large. On the other hand,
inference for n = 200 with 7% censoring appears to be reliable as demonstrated by
95% coverage probabilities that are close to the nominal level. The larger sample
size of 200 also has the added advantage of better numerical stability, with only
10.4% of simulations failing to converge.
Censoring has a strong impact of the performance of the proposed method-
ology. Figure 2.2 considers simulation results for 0%, 7%, and 17% censoring for
the larger sample size of 200. The larger sample size was chosen due to the better
numerical stability. It is clear from the figure that when the censoring reaches the
moderate level of 17%, performance of the proposed method suffers. The stan-
dard errors of the parameters associated with the event time (↵1 and  1) are huge
and there are parameters that are significantly biased based on the empirical con-
fidence intervals. Even the   parameter is not well estimated with a larger amount
of censoring. But, when there is no censoring, the performance of the proposed
method is good. Only 2.8% of the simulations did not converge and the coverage
probabilities are close to the nominal level.
Simulation results, therefore, suggest that the proposed methodology can
be quite useful when there is a larger sample size with a small amount of censoring.
However, care should be taken when the percentage of censoring is high or when
the sample size is small.
2.5.2 DFCI Head and Neck Data
We applied the proposed method to a study of head and neck cancer (HNC) pa-
tients carried out at Dana-Farber Cancer Institute (Chapuy et al., 2011). Patients
were identified for the study through a retrospective chart review andwere eligible
if they were diagnosed between 1998 and 2008 with an advanced-stage squamous
cell carcinoma of the oropharynx, hypopharynx, larynx, or unknown primary and
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were treated with chemoradiotherapy (chemoRT) and neck dissection. Twenty-
four months of follow-up after chemoRT without recurrence was also required for
inclusion. The goal of the study is to determine clinical and treatment factors as-
sociated with dysphagia in this group of HNC patients. Dysphagia, or difficulty
swallowing, is a major concern for HNC patients after treatment because it can
have a negative impact on a patient’s quality of life. However, there is not one
definitive way to measure or define the condition objectively and physicians of-
ten do not want to define the condition subjectively based on patients’ perceptions
of swallowing. Caudell et al. (2009) recognized the usefulness of utilizing mul-
tiple objective measures to describe dysphagia. They created a single composite
endpoint using several objective measures they felt would capture all patients suf-
fering from dysphagia (they believed some patients might be missed using only
a single outcome measure). Chapuy et al. (2011) also used multiple outcomes to
create a score used in the analysis. While the idea of using multiple measurable
outcomes in this way may be an improvement over using a single outcome, it is
not ideal because the composite endpoint or score is defined somewhat arbitrarily.
The investigators at Dana-Farber collected information on several mea-
surable outcomes that are often used to describe dysphagia: time from end of
chemoRT to removal of the gastrostomy tube, weight loss after chemoRT, and diet
(liquid, soft, etc). Using this information they want to identify factors associated
with dysphagia, not factors associated with a single outcome related to dysphagia.
The analysis of this data set is challenging because the outcome of interest, dys-
phagia, is not observable and we have multiple measurable outcomes of mixed
types available that are all attempting to measure dysphagia that we would like to
combine in a meaningful way to evaluate treatment and other factors. Using the
proposed methodology for the analysis will allow us to combine the multiple mea-
surable outcomes through the latent variable structure and then determine factors
associated with the latent variable (dysphagia) as desired by the investigators.
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Eighty-eight patients were eligible for the study. Two patients were ex-
cluded from the analysis because they never had a gastrostomy tube and thus rep-
resent a different patient population. Sixty-six patients were then available with
complete outcome information. We were able to impute weight information using
a later weight measurement (measurement taken at some point after our baseline
of 1 month post chemoRT) for 9 patients, giving us 75 patients available for analy-
sis. For each patient i, let Yi1 be the observed time from end of chemoRT to removal
of the gastrostomy tube in days (note this outcome is potentially censored), Yi2 be
weight loss after chemoRT in kg, and Yi3 be diet (regular, soft, pureed, liquid, no
food; ordinal 1-5). ↵3 will be constrained to be greater than 0 for identifiability. Us-
ing the proposed methodology, ei characterizes the level of dysphagia for patient i
with a larger ei indicating worse dysphagia and Zi is treatment or some other clin-
ical factor potentially associated with dysphagia. In this way,   is the parameter of
primary interest for inference.
When analyzing theHNCdata set, we are hindered by the small sample size
(n = 75). We are unable to fit complex models with many covariates, so instead
we will focus on two models that are small, but clinically interesting. Model 1 will
include T-stage (ordinal) as the Z covariate and sex as the X covariate and Model
2 will include treatment (induction vs. concurrent chemoRT) as the Z covariate
and sex as the X covariate. T-stage is clinically relevant because T-stage has been
shown to be associated with adverse swallowing outcomes previously (Machtay
et al., 2008; Nguyen et al., 2009; Chapuy et al., 2011). Treatment is of interest to
determine if patients treated with induction chemotherapy followed by chemoRT
have worse dysphagia as compared to patients treated with primary concurrent
chemoRT. Sex is included as the X covariate in both models because it is not a
variable of primary interest, but we might want to control for it in the analysis.
Results for Model 1 andModel 2 can be found in Table 2.4. For both models,
none of the   parameters are significant as evidenced by 95% confidence intervals
48
Table 2.4: Head and neck data analysis results
Estimate SE 95% CI
Model 1 (T-stage)
 1 0.154 0.413 (-0.655, 0.964)
 2 -0.582 0.301 (-1.171, 0.008)
 3 -0.220 0.466 (-1.135, 0.694)
↵1 0.577 0.288 (0.012, 1.141)
↵2 0.017 0.127 (-0.233, 0.266)
↵3 1.518 0.614 (0.315, 2.721)
  -0.027 0.356 (-0.724, 0.670)
Model 2 (Treatment)
 1 0.167 0.423 (-0.663, 0.997)
 2 -0.581 0.367 (-1.301, 0.138)
 3 -0.156 0.670 (-1.469, 1.158)
↵1 0.528 0.146 (0.242, 0.815)
↵2 0.019 0.094 (-0.166, 0.204)
↵3 1.341 0.304 (0.746, 1.936)
  0.231 0.401 (-0.554, 1.016)
*For both models sex is the X covariate
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that cover 0. This suggests that sex is not associated with any of the transformed
outcomes included in the model. Also, for both models ↵1 and ↵3 are significant,
but ↵2 is not. The ↵ parameters are factor loadings, so these findings indicate
that time on the gastrostomy tube and diet are significantly associated with the
latent variable (dysphagia). In fact, worse dysphagia is associated with a longer
time on the feeding tube and a more modified diet. Weight loss after chemoRT,
however, does not appear to be significantly related to dysphagia. This is not a
surprising result as clinically we know that weight loss may not be a great measure
of dysphagia. On the one hand, it makes sense that if a patient is having difficulty
swallowing, then that patient is likely to eat less and lose more weight. However,
when the feeding tube is being used, adequate nutrition can be obtained through
the tube without the need to swallow. This would suggest that even if swallowing
is difficult for a patient, this may not be seen through measuring the weight of that
patient. Both Model 1 and Model 2 indicate that weight loss may not be a useful
measure to capture dysphagia.
In Model 1, T-stage is included as the Z covariate. The   parameter asso-
ciated with T-stage in this model is not significant. This suggests that a higher T-
stage (increased size of the primary tumor) is not associatedwithworse dysphagia.
Similarly, from Model 2, there is no evidence of an association between treatment
and dysphagia, meaning that there is not evidence that induction chemotherapy
is associated with worse dysphagia. While neither of the Z covariates considered
were found to be significant, it is important to keep in mind the limitations of the
proposed methodology when interpreting these results. The sample size for the
HNC data is 75 and there is 6.7% censoring. From the simulation results, we know
that inference may not be totally reliable in this setting. In particular, the standard
error estimate for the   parameter may be too large. Therefore, in a larger data set,
we might find an association between one or both of the Z covariates and dyspha-
gia. In this way, a larger sample size would be useful in order to be more certain
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about results obtained using the proposed methodology.
2.6 Discussion
The proposed methodology has a lot of appeal because it uses a semiparametric
approach that does not require pre-specifying a link between the measurable out-
comes and the latent variable of interest. The methodology also has the advantage
of allowing for multiple outcomes of mixed types, including censored outcomes, to
be incorporated into the latent variable framework and being able to estimate the
treatment (or other covariate) effect on the unobserved latent variable. Simulations
suggest that the proposed method has a lot of utility when the sample size is large
and the censoring proportion is small. More specifically, the method performs
well for a sample size of 200 with 7% censoring or less. However, there are some
limitations to this approach that must be acknowledged. In particular, when the
censoring percentage reaches 17%, simulations indicate inference may not reliable.
Also, sample size is a concern. Specifically, a sample size of 100 may be too small to
completely trust inference made using the proposed method. As noted previously,
there is evidence of some numerical instability in the estimation algorithm when
the sample size is small. A larger sample size is likely required because of the large
number of parameters that must be estimated, either in the transformation func-
tions or through the likelihood. In the end, a small sample likely does not contain
enough information to reliably estimate all of the pieces. Despite these limitations,
a sample size of 200 or more is not unreasonable in many potential applications.
Another potential limitation of the proposed method is the use of a thresh-
old model for discrete measurable outcomes. The threshold model is practical
because then we have all continuous outcomes that can be jointly modeled using
the multivariate normal. However, this means that nominal measurable outcomes
cannot be meaningfully incorporated in this approach. Also, in order to use the
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threshold approach, it must be plausible that there is some underlying continuous
quantity that gives rise to the ordinal categories that are observed. In the HNC
case, the ordinal outcome is diet and it is plausible that there is some underly-
ing biological quantity that determines the change from one food type to another.
However, it is possible the threshold approach would not make sense in a different
application. Choosing which covariates should be X covariates and which should
be Z covariates is also an issue. In general, if you want to be able to look at the
association between a covariate and the latent variable, then that covariate should
be included in Z. However, there is not a good statistical approach to make this
decision.
This methodology was motivated by the question of what treatment and
clinical factors are associated with dysphagia in HNC patients. We are limited in
our ability to address this clinical question, however, by having only 75 patients
available for analysis. We were able to fit two simple models to the HNC data,
but it is not clear how meaningful these results would be in the clinical literature.
Despite the limitations of the proposed method in small samples, the semipara-
metric approach could have great utility in informing a parametric model of the
same form as models (2.1) and (2.2), but with the link functions pre-specified. In
particular, we can use the estimated transformations that arise out of the proposed
methodology to decide on appropriate link functions for a parametric model. Fig-
ure 2.3 presents the estimated transformations obtained from Model 1. Based on
this plot, it would seem reasonable to use either a log or square root transforma-
tion for the time on the gastrostomy tube. Using the identity link (i.e. assuming
normality) for weight loss also seems appropriate. As discussed previously, the
semiparametric method proposed in this paper is a useful approach for analysis
when the sample size is large. In addition, we suggest that the proposed method
has a very practical use, even in a smaller sample, in informing a parametric ver-
sion of the method.
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Exploring Dysphagia in Head and Neck Cancer
Patients: A Latent Variable Transformation Model
Approach
Anna C. Snavely, David Harrington, and Yi Li
3.1 Abstract
Dysphagia, or difficulty swallowing, is a common issue for head and neck cancer
patients post treatment. Quality of life is negatively impacted by swallowing dif-
ficulty, so it is important to understand clinical and treatment factors that might
be related to the condition. The challenge here is that dysphagia, our outcome
of interest, cannot be measured directly. Instead, there are multiple measurable
outcomes of mixed types available that are all attempting to capture some aspect
of dysphagia. In this paper we propose a latent variable normal transformation
model where the measurable outcomes are assumed to be governed by an unob-
served (latent) variable, which in turn may depend on covariates such as treat-
ment. This approach has the advantage of incorporating measurable outcomes
that are both discrete and continuous. In particular, the proposed method extends
traditional methods by including measurable outcomes that are subject to censor-
ing. Through the structure of the model we are able to study the effect of covariates
on the latent variable, which in our case represents dysphagia, greatly enhancing
the interpretability of the model. The methodology is applied to a study of head
and neck cancer patients from Dana-Farber Cancer Institute.
3.2 Introduction
Squamous cell carcinoma of the head and neck represents about 5% of newly di-
agnosed cancers in adults in the United States. These patients tend to present with
locally advanced disease and are treated aggressively with some combination of
surgery, chemotherapy, and radiotherapy (Posner et al., 2007). Intensive chemora-
diation (chemoRT) regimens have been found to be effective in the management
of head and neck cancer (HNC) in terms of improving both progression free and
overall survival (Pignon et al., 2000). With aggressive chemoRT treatment, how-
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ever, comes side effects such as dysphagia, or difficulty swallowing, that have a
negative impact on a patient’s quality of life (Goguen et al., 2006; Nguyen et al.,
2009). Having a neck dissection (surgical procedure to remove lymph nodes in
the neck) following chemoRT may have an additional impact on swallowing func-
tion as seen in Machtay et al. (2008) and Lango et al. (2010). With more patients
surviving after aggressive treatment, understanding what factors may be related
to dysphagia becomes important as quality of life becomes a critical consideration
for both patients and physicians.
Investigators at Dana-Farber Cancer Institute (DFCI) carried out a study
with the goal of exploring treatment and clinical factors that may be associated
with dysphagia (Chapuy et al., 2011). This goal is challenging, however, because
there is not one definitive way to measure or define dysphagia objectively. Physi-
cians often do not want to define the condition subjectively based on patients’ per-
ceptions of swallowing because patient reported outcomes have not been found
to be well correlated with more objective measures such as videofluoroscopy find-
ings (Caudell et al., 2009). In order to best capture dysphagia, the use of multiple
objective measures has been suggested (Caudell et al., 2009; Chapuy et al., 2011).
This has resulted in analysis based on a single composite endpoint or score based
on objective measures. This approach may be an improvement over using a sin-
gle outcome, but it is not ideal because the composite endpoint or score is defined
somewhat arbitrarily. Instead, we propose a latent variable normal transformation
model to handle this analysis. In the proposed model, measurable outcomes of
mixed types (including event times) are assumed to be governed by an unobserved
(latent) variable, which in turn may depend on covariates such as treatment. This
approach has the advantage of incorporating measurable outcomes that are both
discrete and continuous. In particular, the proposed method extends traditional
methods by including measurable outcomes that are subject to censoring. Also,
through the structure of the model we are able to study the effect of covariates on
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the latent variable, greatly enhancing the interpretability of the model. In the HNC
setting, the measurable outcomes are the objective measures available for captur-
ing dysphagia and the latent variable represents dysphagia itself, our outcome of
interest. This approach, therefore, will allow us to combine the multiple measur-
able outcomes in a meaningful way through the latent variable structure and then
determine factors associated with the latent variable (dysphagia) as desired by the
investigators.
The particulars of the DFCI study will be described in Section 3.3 and the
model will be specified and discussed in Section 3.4. Simulation results will be
presented in Section 3.5, followed by data analysis results in Section 3.6. We will
wrap-up with a discussion in Section 3.7.
3.3 DFCI Head and Neck Study
Investigators at Dana-Farber conducted a retrospective study to learn about dys-
phagia in HNC patients treated with chemoRT and neck dissection (Chapuy et al.,
2011). Both electronic and paper medical records were reviewed to identify eli-
gible patients. Patients were included in the study if they were diagnosed with
an advanced-stage squamous cell carcinoma of the oropharynx, hypopharynx, lar-
ynx, or unknown primary and were treated at DFCI between January 1998 and
June 2008 with chemoRT and neck dissection. All patients had at least twenty-
four months of follow-up after chemoRT without recurrence and had a primary
site complete response to chemoRT at the time of neck dissection. The 88 patients
found to be eligible for the study, therefore, represent a group of patients who had
advanced disease and responded well to aggressive treatment (no recurrence for
at least two years). Quality of life is an important consideration for this subset of
patients, so learning more about dysphagia in this group is particularly relevant.
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Since there is no direct objective measure for dysphagia, the DFCI inves-
tigators collected information on several measurable outcomes that can be used
as surrogate measures for dysphagia: time from end of chemoRT to removal of
the gastrostomy tube, weight loss after chemoRT, and diet (regular, soft, pureed,
liquid, no food). Time from end of chemoRT to gastrostomy tube (feeding tube
directly into the stomach) removal is an event time subject to censoring. The cen-
soring in this case is administrative (i.e. feeding tube still in place at the end of
follow-up). We would expect a longer time on the feeding tube to be indicative
of worse dysphagia. Weight loss after chemoRT is continuous. We might expect
that a greater weight loss would be associated with worse dysphagia. However,
this may not be true if the patient is getting adequate nutrition through the feeding
tube. In this way, it is not clear that weight loss is a great surrogate measure for
dysphagia. Diet is an ordinal variable that characterizes how modified a patient’s
diet is, with a more modified diet expected to be related to worse dysphagia. Both
weight loss and diet are measured at baseline, which is 1 month after the end of
chemoRT. As an important note, because the feeding tube is a gastrostomy tube, it
is possible for a patient to still have a feeding tube in place and be able to eat food
by mouth. In other words, having a feeding tube in place does not automatically
restrict a patient to the “no food” diet category.
Of the 88 patients that were eligible for the study, 75 will be used for the
analysis. Two patients were excluded because they never had a gastrostomy tube
placed and thus represent a different patient population. After the 2 exclusions,
there were 66 patients with complete outcome information. In order to increase
the sample size and make use of as much data as possible, we imputed weight
information using a later weight measurement (measurement taken at some point
after our baseline of 1 month post chemoRT) for 9 patients. This gives us 75 pa-
tients available for analysis. This is the same set of patients that is analyzed in
Chapter 2.
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3.4 Latent Variable Transformation Model
3.4.1 Background and Model Specification
Latent variable models were introduced in the field of psychology with the first
methods being attributed to Spearman (1904). Spearman’s methodology lead to
the development of factor analysis and other latent variable approaches that have
been used extensively in both psychology and education. Use of latent variable
methods in the biomedical setting has increased over time, particularly as latent
variable methodology has been further developed (see, for example, Sammel &
Ryan (1996); Roy & Lin (2000); Sammel et al. (1997); Moustaki & Knott (2000); Dun-
son (2006)).
For the analysis of the DFCI head and neck data, we propose a latent vari-
able model that builds on the basic structure of Sammel & Ryan (1996). The model
suggested by Sammel & Ryan (1996) only allows for continuous measurable out-
comes, however, so we extend their approach by including discrete outcomes by
linking the discrete outcomes to underlying continuous outcomes as originally
considered in Muthe´n (1984). The underlying continuous variables can then be
incorporated in the multivariate normal structure. We also add additional flexibil-
ity by considering transformed outcomes and allowing for censored measurable
outcomes. These extensions will allow us to incorporate events times, continuous
outcomes, and ordinal outcomes as measurable outcomes in the latent variable
framework as required by the HNC data. Figure 3.1 presents a diagram of the ba-
sic model structure. In short, measurable outcomes of mixed types are assumed
to be governed by a latent variable (e), which in turn may depend on covariates
(Z) such as treatment. Additional covariates, X , may also be related to the mea-
surable outcomes. The actual modeling is done on all continuous variables and
transformations, H , are allowed. The transformation functions, however, must be
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Figure 3.1: Diagram of basic model structure for the latent variable transformation ap-
proach.
pre-specified.
Specifically, suppose there are n subjects with p distinct measurable out-
comes. For simplicity, we will consider the setting where there is a single measur-
able outcome that is subject to censoring. The extension to accommodate multiple
censored outcomes, however, is rather straightforward. Without loss of generality
wewill assume that the event time, T , is the first measurable outcome. C is then the
corresponding censoring variable. We assume that T and C are independent and
also that C is independent of the covariates. For individual i, let Yi1 = min(Ti, Ci)
and  i = I(Yi1 = Ti), where I(·) is the indicator function. Then, for each indi-
vidual, we observe vectors of covariates Xi1, · · · , Xip (e.g. age and gender) and
Zi (e.g. treatment), a failure indicator  i, and a vector of measurable outcomes
Yi = (Yi1, · · · , Yip)T . The elements of Yi are ordered such that the first p1 elements
are continuous (with the first element being the event time), and the remaining
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p2 = p  p1 elements are discrete (binary, ordinal, or count outcomes are possible).
In order to facilitate joint modeling, the discrete measurable outcomes are
linked to underlying continuous variables as in Muthe´n (1984) and Dunson (2006).
Let Y uij be a continuous variable underlying Yij . Then, for the discrete outcomes,
for Yij 2 {1, · · · , dj}, we have Yij =
Pdj
l=1 lI(cj(l   1) < Y uij  cj(l)) where dj is
the number of categories for the jth outcome and cj = (cj(0), · · · , cj(dj))T are un-
known thresholds satisfying  1 = cj(0) < · · · < cj(dj) = 1. For the measurable
outcomes that are already continuous, Yij is simply equal to Y uij .
The continuous or underlying continuous outcomes can now be related to
the latent variable (ei) of primary interest through the following model:
H1(Ti) = X
T
i1 1 + ↵1ei + "i1,
H2(Y
u
i2) = X
T
i2 2 + ↵2ei + "i2, (3.1)
...
Hp(Y
u
ip) = X
T
ip p + ↵pei + "ip.
In model (3.1),   = ( T1 , · · · ,  Tp )T is a vector of regression coefficients,
↵ = (↵1, · · · ,↵p)T are factor loadings, ei is a latent variable for subject
i, and "i = ("i1, · · · , "ip)T is a vector of independent errors distributed as
N(0, diag( 21, · · · ,  2p)). The Hs are pre-specified monotone transformation func-
tions. A typical choice for the event time would a log transformation. The iden-
tity link may be an appropriate choice for many continuous measurable outcomes
(i.e. assume normality). For the discrete measurable outcomes, a transformation
does not need to be specified since we do not observe the underlying continuous
variable. Transformed thresholds (Hj(cj(1)), · · · , Hj(cj(dj   1))) can be estimated
through the likelihood, where the assumption is that the underlying continuous
variable has been transformed to be normally distributed.
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The latent variable is assumed to have additional structure as follows:
ei = Z
T
i   + ✏i, (3.2)
where Zi records covariates of interest such as treatment,   is a vector of unknown
regression coefficients, and ✏i is the random error distributed as N(0,  2e). In most
instances,   is the primary parameter for inference since it relates important co-
variates to the latent variable (outcome of interest). We assume that Zi and ✏i are
independent and that for identifiability, Zi and Xij do not contain constant terms,
 2e = 1, and  2j = 1 for j = p1+1, · · · , p (discrete measurable outcomes). One of the
factor loadings is also constrained to be positive (Dunson, 2003).
3.4.2 Likelihood Specification and Parameter Estimation
Since the error terms in models (3.1) and (3.2) are assumed to be normally dis-
tributed, the vector of transformed continuous outcomes follows a multivariate
normal distribution. The likelihood, however, is not simply a multivariate nor-
mal density because not all of the outcomes are completely observed. For each
given yj 2 {1, · · · , dj} for j = p1 + 1, · · · , p (the discrete measurable outcomes),
let H˜j(yj) = Hj(cj(yj)), where cj is the unknown upper limit of Y uij when Yij = yj .
For the continuous measurable outcomes, let H˜j = Hj . Then if ⇥ = ( ,↵,  ) and
H˜ = (H˜1, · · · , H˜p), the likelihood can be expressed as:
L(⇥; H˜) / |⌃22|n/2
nY
i=1
Z
x[2]2H[2]i
exp
24 1
2
  
H˜[1]i
x[2]
!
 Xi    ↵ TZi
!T
⌃ 122
  
H˜[1]i
x[2]
!
 Xi    ↵ TZi
!35 dx[2], (3.3)
where Xi = diag(XTi1, · · · , XTip), H˜[1]i = (H˜1(Y ui1), · · · , H˜p1(Y uip1))T , H˜[2]i =
(H˜p1+1(Y
u
i,p1+1), · · · , H˜p(Y uip))T , andH[2]i =
Qp
j=p1+1
[H˜j(Yij), H˜j(Yij + 1)].
The likelihood (3.3) arises from the fact that based on models (3.1) and
(3.2), H˜i ⌘ (H˜[1]Ti , H˜[2]
T
i )
T ⇠ N(Xi  + ↵ TZi,⌃22), where ⌃22 = ↵↵T +  ,
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 = diag( 21, · · · ,  2p)), and  2j = 1 for j = p1 + 1, · · · , p (discrete measurable out-
comes). The integrals in the likelihood are required because not all of the measur-
able outcomes are completely observed. In particular, H˜[1]i is completely observed
(as long as the event time is not censored), however H˜[2]i is only known to fall in
H[2]i . In the case of a censored event time, the event time can also be incorporated in
H˜[2]i and the bounds of integration for the event time ( [H˜1(Yi1),1]) can be included
inH[2]i (since now the time is not completely observed).
The model parameters most relevant for inference are  , ↵, and  . However,
the transformed thresholds associated with the discrete measurable outcomes and
the variance parameters associated with the continuous measurable outcomes also
need to be estimated. All of these parameters can be estimated through maximiz-
ing the likelihood (3.3).
Many different maximization routines could be considered, but we have
opted to use the Broyden-Fletcher-Goldfarb-Shanno (BFGS) method. BFGS is a
quasi-Newton method that often performs well for complex optimization prob-
lems (Press et al., 1992). Whatever method is used, however, must support a con-
strained maximization. For each discrete measurable outcome, the transformed
thresholds must be constrained to be ordered, and one of the factor loadings (i.e.
one of the ↵ parameters) must be constrained to be positive. Because this is a con-
strained optimization problem, inference based on likelihood theory could be in-
correct. However, simulation results suggest that the model based standard errors
arising from the likelihood are reliable and, therefore, inference based on these
standard errors is reasonable. In other words, the constraints do not appear to
cause boundary issues in this setting and traditional likelihood theory can be used
for inference.
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3.4.3 Model Checking
The transformation functions, H , must be pre-specified in order to use this para-
metric latent variable transformation model. Choosing an appropriate transfor-
mation can be a challenge, however, so it would be useful to have guidance in
selecting a transformation and a means of diagnosing a misspecified transforma-
tion.
Chapter 2 presented a semiparametric latent variable transformation
model. In this approach, the transformations are estimated using the data instead
of being pre-specified. Estimated transformations (in the form of step functions)
can be obtained through the estimation procedure. These step functions can then
be used to inform a parametric model. For example, the shape of an estimated
transformation from the semiparametric approach might suggest using a log link
in a parametric model.
After a parametric model has been fit, residuals can be used to consider
model fit. Residuals can be obtained separately for each of the measurable
outcomes. In the continuous case the residuals will be: Hj(yij)   XTij  ˆj + ↵ˆjZTi  ˆ.
In other words, the residuals are simply the observed transformed outcome
minus the predicted transformed outcome from the model. Similar to the linear
regression setting, these residuals should be normally distributed and have mean
0. Also, we would not expect to see a pattern in the residuals in a plot of the
residuals vs. the fitted values if the model fits well. A misspecified transformation
should be noticeable in the residual plots. Figures 3.2 and 3.3 show residual plots
for a correctly specified model. Both the density and Q-Q plots suggest that there
are no major departures from normality and the Residuals vs. Fitted plot shows
no recognizable pattern.
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Figure 3.2: Plot looking at the normality of the residuals for the event time for the correct
model (log link).
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Figure 3.3: Plot of residuals vs. fitted values for the event time for the correct model (log
link).
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Figure 3.4: Plot looking at the normality of the residuals for the event time when the trans-
formation is misspecified (square root instead of log link).
Figures 3.4 and 3.5 show residual plots for a model where the event time
transformation is misspecified. The true transformation is a square root, but the
model assumes a log link. Clear departures from normality are seen by the long
left tail in the density plot and the curved shape of the residuals in the Q-Q plot.
The Residuals vs. Fitted plot shows a few residuals that are very small. These
residual plots can be very useful is diagnosing an incorrect transformation and in
general, such plots are useful in assessing model fit.
For the discrete measurable outcomes, the underlying continuous variable
can be predicted from the model by XTij  ˆj + ↵ˆjZTi  ˆ. The estimated transformed
thresholds can then be applied to the underlying continuous variables to get a
predicted category for each individual, i. Model fit could then be assessed by
seeing how well the predicted categories and observed categories match up in a
cross-classified table. Association could be assessed using a Fisher’s Exact test, but
there is limited power for this kind of test, particularly in a small sample.
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Figure 3.5: Plot of residuals vs. fitted values for the event time when the transformation is
misspecified (square root instead of log link).
3.5 Simulation Studies
We used simulations to evaluate the performance of the latent variable transforma-
tion model. Since this methodology was proposed to analyze the DFCI head and
neck data, the simulations were designed to mimic the HNC data structure. Three
measurable outcomes were, therefore, considered in the simulations: an event time
outcome, a continuous outcome, and an ordinal outcome with 5 categories. The
following model was fit to the simulated data:
log(Ti) = Xi 1 + ↵1ei + "i1,
Yi2 = Xi 2 + ↵2ei + "i2, (3.4)
Y ui3 = Xi 3 + ↵3ei + "i3,
and
ei = Zi  + ✏i. (3.5)
In the simulations considered we assumed that there was a single continu-
ous X covariate common to all three measurable outcomes and a single binary Z
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covariate to represent treatment or some other binary covariate of interest. Specif-
ically, Xi ⇠ N(0, 1), Zi ⇠ Bernoulli(0.50), and the true parameter values were se-
lected to be  1 = 0.5,  2 = 0.9,  3 = 0.75, ↵1 = 0.5, ↵2 = 0.9, ↵3 = 0.75,   = 1.
The underlying continuous variables were then generated from the multivariate
normal, N(Xi  + ↵ Zi,⌃22), where ⌃22 = ↵↵T +  .  = diag( 21,  22, 1) and we
assume that  1 = 1 and  2 = 1, or in other words, ⌃22 = ↵↵T +I3⇥3. Generating the
data in this way ensures that the measurable outcomes are correlated through the
↵ parameters. For the correctly specified model, the event time outcome was then
created through an anti-log transformation with censoring introduced through an
exponential random variable. The parameter for the exponential distribution was
chosen to give a particular percentage of censoring. The continuous outcome did
not require further transformation for the correctly specifiedmodel. Finally, the or-
dinal outcome was obtained by using the underlying continuous variable arising
from the multivariate normal model and then applying the following thresholds:
(-1, -1, 0, 1, 2,1).
3.5.1 Correctly Specified Model Results
Eight simulation settings were considered to explore performance of the latent
variable transformation approach. For each setting, 250 simulations were carried
out. Two different sample sizes were explored: n = 100 and n = 200, and four dif-
ferent censoring levels were considered: 0%, 7%, 17%, and 50%. The 7% censoring
was chosen to match the HNC data and the 50% censoring was chosen to illustrate
a higher censoring setting. Primary parameter results ( , ↵, and  ) for n = 100 can
be found in Table 3.1. Corresponding results for n = 200 are presented in Table
3.2. Secondary parameter results (transformed thresholds and standard deviation
parameters) for both sample sizes are included in Table 3.3.
Overall, simulation results suggest that the performance of the latent vari-
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Table 3.1: Simulation results for n = 100 (primary parameters)
 1  2  3 ↵1 ↵2 ↵3  
0% Censoring
Mean 0.504 0.900 0.825 0.497 0.902 0.852 1.042
Bias 0.004 <0.001 0.075 -0.003 0.002 0.102 0.042
Empirical SE 0.121 0.132 0.522 0.110 0.161 0.897 0.251
Model SE 0.112 0.135 0.198 0.109 0.158 0.254 0.246
95% CI Coverage 0.952 0.944 0.964 0.956 0.960 0.968 0.952
7% Censoring
Mean 0.497 0.912 0.795 0.480 0.876 0.788 1.065
Bias -0.003 0.012 0.045 -0.020 -0.024 0.038 0.065
Empirical SE 0.114 0.137 0.173 0.107 0.169 0.223 0.275
Model SE 0.113 0.133 0.183 0.110 0.157 0.240 0.249
95% CI Coverage 0.952 0.956 0.972 0.968 0.940 0.968 0.920
17% Censoring
Mean 0.493 0.880 0.786 0.494 0.882 0.826 1.030
Bias -0.007 -0.020 0.036 -0.006 -0.018 0.076 0.030
Empirical SE 0.118 0.147 0.198 0.121 0.141 0.269 0.240
Model SE 0.116 0.134 0.203 0.116 0.159 0.283 0.244
95% CI Coverage 0.948 0.932 0.952 0.936 0.976 0.956 0.940
50% Censoring
Mean 0.493 0.881 0.779 0.497 0.885 0.811 1.028
Bias -0.007 -0.019 0.029 -0.003 -0.015 0.061 0.028
Empirical SE 0.138 0.148 0.178 0.147 0.148 0.239 0.239
Model SE 0.131 0.134 0.202 0.136 0.168 0.285 0.250
95% CI Coverage 0.951 0.930 0.963 0.942 0.971 0.988 0.963
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Table 3.2: Simulation results for n = 200 (primary parameters)
 1  2  3 ↵1 ↵2 ↵3  
0% Censoring
Mean 0.496 0.906 0.787 0.494 0.888 0.774 1.030
Bias -0.004 0.006 0.037 -0.006 -0.012 0.024 0.030
Empirical SE 0.074 0.098 0.125 0.078 0.110 0.173 0.180
Model SE 0.079 0.095 0.123 0.077 0.111 0.160 0.169
95% CI Coverage 0.964 0.948 0.944 0.952 0.960 0.944 0.920
7% Censoring
Mean 0.506 0.903 0.781 0.500 0.900 0.780 1.020
Bias 0.006 0.003 0.031 <0.001 <0.001 0.030 0.020
Empirical SE 0.082 0.101 0.132 0.073 0.118 0.162 0.168
Model SE 0.080 0.096 0.123 0.078 0.110 0.159 0.167
95% CI Coverage 0.944 0.948 0.932 0.960 0.928 0.944 0.956
17% Censoring
Mean 0.492 0.906 0.772 0.487 0.889 0.768 1.020
Bias -0.008 0.006 0.022 -0.013 -0.011 0.018 0.020
Empirical SE 0.084 0.099 0.117 0.078 0.105 0.164 0.172
Model SE 0.082 0.095 0.121 0.081 0.113 0.159 0.170
95% CI Coverage 0.940 0.936 0.968 0.956 0.964 0.936 0.940
50% Censoring
Mean 0.489 0.906 0.770 0.486 0.894 0.764 1.017
Bias -0.011 0.006 0.020 -0.014 -0.006 0.014 0.017
Empirical SE 0.100 0.099 0.117 0.093 0.112 0.167 0.183
Model SE 0.093 0.095 0.122 0.095 0.118 0.163 0.174
95% CI Coverage 0.928 0.936 0.968 0.948 0.964 0.952 0.928
70
Table 3.3: Simulation results - estimates of secondary parameters
H3(c3(1)) H3(c3(2)) H3(c3(3)) H3(c3(4))  1  2
n=100
0% Censoring -1.064 0.035 1.125 2.234 0.886 0.926
7% Censoring -1.029 0.028 1.075 2.132 0.905 0.910
17% Censoring -1.061 0.014 1.079 2.151 0.926 0.855
50% Censoring -1.061 0.007 1.064 2.127 0.965 0.919
n=200
0% Censoring -1.031 0.009 1.038 2.063 0.989 0.995
7% Censoring -1.013 0.011 1.036 2.082 0.992 0.978
17% Censoring -1.029 -0.002 1.033 2.053 0.992 0.982
50% Censoring -1.029 -0.005 1.028 2.048 0.983 0.976
*True thresholds are: -1, 0, 1, 2. True standard deviations are 1.
able transformation model is quite good in a variety of settings. In particular, the
bias for the  , ↵, and   parameters is consistently small and the coverage prob-
abilities all tend to be close to the nominal level. A higher censoring percentage
does not create estimation difficulties, but rather simply increases standard errors
a bit. The model based standard errors tend to be quite close to the empirical stan-
dard errors, suggesting that inference based on these model based standard errors
should be reliable. The noticeable exception to this is for the  3 and ↵3 parameters
for n = 100. In this case, the model based standard errors are small relative to the
empirical standard errors. The large empirical standard errors are driven by 2 sim-
ulations with extreme values. When the sample size is smaller, there are occasional
situations (⇠1%) when the maximum likelihood estimation fails (seen by standard
error estimates that are listed as NA) or where results are not reliable (seen by ex-
ceptionally large parameter estimates). These situations, however, should be easily
recognizable by an analyst and should be treated as a model that cannot be reliably
fit.
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Table 3.4: Simulation results for n = 75 with 7% censoring to mimic HNC data
 1  2  3 ↵1 ↵2 ↵3  
Mean 0.512 0.913 0.836 0.503 0.879 0.834 1.050
Bias 0.012 0.013 0.086 0.003 -0.021 0.084 0.050
Empirical SE 0.126 0.151 0.285 0.132 0.189 0.479 0.316
Model SE 0.131 0.155 0.235 0.130 0.182 0.318 0.299
95% CI Coverage 0.959 0.951 0.955 0.963 0.959 0.939 0.943
H3(c3(1)) H3(c3(2)) H3(c3(3)) H3(c3(4))  1  2
Mean -1.084 0.012 1.107 2.254 0.931 0.926
*True thresholds are: -1, 0, 1, 2. True standard deviations are 1.
The benefits of an increased sample size are illustrated in Table 3.3. The
transformed thresholds tend to be somewhat better estimated in a larger sample
and the standard deviation estimates are definitely improved in a larger sample.
A larger sample is, therefore, preferable. However, results in Table 3.1 suggest
that even with a smaller sample size, inference of the primary parameters is quite
reasonable.
To further evaluate performance of the method for the DFCI head and neck
data specifically, we considered a simulation with n = 75 and censoring of 7%. Re-
sults for this setting can be found in Table 3.4. Results in this case are very similar
to the setting when n = 100. The biggest change is that there are a fewmore simula-
tions where the maximum likelihood estimation fails, but this still only represents
a little over 2% of simulations. This occasional instability likely arises from the
fact that we are trying to estimate 13 parameters with only 75 subjects. Overall,
however, the latent variable transformation model seems like a reasonable analy-
sis approach for the HNC data as long as maximum likelihood estimation does not
fail for the particular model being fit.
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3.5.2 Misspecified Model Results
Because the transformations must be pre-specified in this approach, we may be
particularly interested in the impact on parameter estimates when the transforma-
tions are misspecified. The event time outcome usually will require some transfor-
mation. A log link would be a logical choice, but may not always be the appro-
priate link function. In Tables 3.5, 3.6, and 3.7 we present simulation results for
the setting where a log link is fit to the data, but a square root link should have
been used. In other words, the event time data were generated through a square
transformation instead of an anti-log transformation.
For the larger sample size of 200, we see that the parameters associated
with the event time ( 1, ↵1, and  1) are biased. However, this is to be expected
since these parameters would now have a different interpretation. The other pa-
rameters, however, are still well estimated. In particular,   still has a fairly small
bias and good coverage probability. This would suggest that misspecifying the
event time link in this way should not have a major impact on the inference for  ,
which is of primary interest for answering the clinical question. When the sample
size is decreased to 100, the estimation of  , as well as  3 and ↵3 (the parameters
associated with the ordinal measurable outcome), is not quite as good. There is
a bit larger absolute bias for these parameters than with the larger sample size,
though the coverage probabilities are still quite good. Also, the smaller sample
size with misspecification of the event time link leads to a bit more instability in
the maximum likelihood procedure. The percentage of simulations that cannot be
estimated through maximum likelihood, however, is still under 7%.
We also considered the scenario when both the event time and continuous
links were misspecified. The event time link was misspecified in the same way
as before. The continuous measurable outcome was generated using an anti-log
transformation, but the identity link was fit to the data. Results for this setting are
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Table 3.5: Simulation results for n = 100 (primary parameters); event time link misspecified
 1  2  3 ↵1 ↵2 ↵3  
0% Censoring
Mean 0.185 0.901 0.892 -0.253 0.871 0.948 1.175
Bias -0.315 0.001 0.142 -0.753 -0.029 0.198 0.175
Empirical SE 0.235 0.133 1.096 0.226 0.229 1.796 0.811
Model SE 0.231 0.135 0.219 0.217 0.205 0.324 0.348
95% CI Coverage 0.942 0.942 0.959 0.950 0.913 0.954 0.959
7% Censoring
Mean 0.170 0.907 0.939 -0.199 0.856 1.014 1.138
Bias -0.330 0.007 0.189 -0.699 -0.044 0.264 0.138
Empirical SE 0.236 0.136 1.206 0.230 0.235 1.968 0.382
Model SE 0.239 0.132 0.235 0.226 0.199 0.334 0.355
95% CI Coverage 0.962 0.954 0.950 0.941 0.908 0.941 0.941
17% Censoring
Mean 0.149 0.883 0.924 -0.181 0.859 1.047 1.101
Bias -0.351 -0.017 0.174 -0.681 -0.041 0.297 0.101
Empirical SE 0.254 0.148 1.242 0.237 0.199 2.169 0.307
Model SE 0.252 0.134 0.244 0.243 0.199 0.351 0.315
95% CI Coverage 0.944 0.927 0.962 0.953 0.940 0.970 0.944
50% Censoring
Mean 0.175 0.879 0.881 0.034 0.894 0.994 1.036
Bias -0.25 -0.021 0.131 -0.466 -0.006 0.244 0.036
Empirical SE 0.338 0.148 0.820 0.322 0.194 1.487 0.271
Model SE 0.330 0.134 0.248 0.329 0.209 0.374 0.287
95% CI Coverage 0.951 0.930 0.959 0.951 0.959 0.971 0.959
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Table 3.6: Simulation results for n = 200 (primary parameters); event time link misspecified
 1  2  3 ↵1 ↵2 ↵3  
0% Censoring
Mean 0.161 0.905 0.842 -0.249 0.840 0.846 1.102
Bias -0.339 0.005 0.092 -0.749 -0.060 0.096 0.102
Empirical SE 0.153 0.098 0.734 0.158 0.187 1.028 0.299
Model SE 0.163 0.095 0.143 0.156 0.144 0.215 0.226
95% CI Coverage 0.972 0.955 0.967 0.931 0.907 0.963 0.939
7% Censoring
Mean 0.148 0.903 0.788 -0.213 0.878 0.788 1.072
Bias -0.352 0.003 0.038 -0.713 -0.022 0.038 0.072
Empirical SE 0.161 0.102 0.148 0.160 0.164 0.219 0.215
Model SE 0.172 0.096 0.140 0.164 0.145 0.207 0.208
95% CI Coverage 0.972 0.948 0.952 0.944 0.907 0.964 0.944
17% Censoring
Mean 0.169 0.906 0.778 -0.214 0.864 0.770 1.076
Bias -0.331 0.006 0.028 -0.714 -0.036 0.020 0.076
Empirical SE 0.182 0.100 0.126 0.163 0.153 0.187 0.230
Model SE 0.178 0.094 0.132 0.172 0.145 0.196 0.210
95% CI Coverage 0.935 0.935 0.955 0.967 0.943 0.963 0.955
50% Censoring
Mean 0.198 0.906 0.776 -0.023 0.900 0.770 1.022
Bias -0.302 0.006 0.026 -0.523 <0.001 0.020 0.022
Empirical SE 0.237 0.099 0.127 0.218 0.154 0.211 0.209
Model SE 0.230 0.095 0.134 0.225 0.149 0.198 0.198
95% CI Coverage 0.944 0.936 0.968 0.980 0.932 0.952 0.956
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Table 3.7: Simulation results - estimates of secondary parameters; event time link misspec-
ified
H3(c3(1)) H3(c3(2)) H3(c3(3)) H3(c3(4))  1  2
n=100
0% Censoring -1.073 0.116 1.287 2.474 2.063 0.825
7% Censoring -1.165 0.085 1.323 2.568 2.196 0.774
17% Censoring -1.174 0.092 1.335 2.557 2.267 0.762
50% Censoring -1.171 0.048 1.248 2.459 2.754 0.849
n=200
0% Censoring -1.056 0.058 1.150 2.226 2.115 0.910
7% Censoring -0.992 0.044 1.080 2.132 2.201 0.959
17% Censoring -1.008 0.027 1.068 2.092 2.311 0.945
50% Censoring -1.033 -0.001 1.040 2.068 2.706 0.925
*True thresholds are: -1, 0, 1, 2. True standard deviations are 1.
not shown, but it is important to note that this amount of misspecification leads to
a fairly unstable maximum likelihood procedure (maximum likelihood estimation
failed for as many as 30% of simulations) and leads to substantial bias in all of
the parameters. The use of the semiparametric procedure to inform a parametric
model and the use of residuals should help to avoid this scenario, however.
3.6 DFCI Head and Neck Data Analysis
We have 75 patients available for analysis from the DFCI head and neck study.
Because we are dealing with a rather small sample size, we are limited in the com-
plexity of the models that can be fit to the data. Also, from the simulation studies
we know that when there is a small sample size maximum likelihood estimation
may fail for some models. Despite these limitations, we were able to fit a number
of models to the HNC data.
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All models utilized the same three measurable outcomes, but differed in the
covariates included and the link function assumed for the event time. Specifically,
the measurable outcomes are defined as follows for patient i: Yi1 is the observed
time from end of chemoRT to removal of the gastrostomy tube in days (note this
outcome is potentially censored), Yi2 is weight loss after chemoRT in kg, and Yi3
is diet (regular, soft, pureed, liquid, no food; ordinal 1-5). For identifiability, ↵3 is
constrained to be greater than 0. Using the latent variable transformation structure,
ei characterizes the level of dysphagia for patient iwith a larger ei indicating worse
dysphagia. Zi is treatment or some other clinical factor of interest that is potentially
associated with dysphagia. In this way,   is the parameter of primary interest for
inference.
We found that using a log link for the time on the feeding tube and an iden-
tity link for weight loss after chemoRT provided the best performance. After con-
sidering a number of different models with varying covariates, the model that best
fit the data did not include any X covariates, but included both treatment and
T-stage as Z covariates. Both treatment (Zi1) and T-stage (Zi2) were of particular
interest to the DFCI investigators. Treatment here is an indicator of having induc-
tion chemotherapy in addition to chemoRT. Treatment is of interest to determine if
patients treated with the more aggressive induction chemotherapy followed by
chemoRT have worse dysphagia as compared to patients treated with primary
concurrent chemoRT. T-stage is clinically relevant because it has been shown to
be associated with adverse swallowing outcomes in the literature (Machtay et al.,
2008; Nguyen et al., 2009; Chapuy et al., 2011).
Results for this model can be found in Table 3.8. In particular all of the
factor loadings are significant, suggesting that all three of our surrogate measures
are contributing information about dysphagia. Specifically, a longer time on the
feeding tube is associated with worse dysphagia, more weight loss after chemoRT
is associated with worse dysphagia, and a more modified diet is associated with
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Table 3.8: Final head and neck results including treatment (Zi1) and T-stage (Zi2)
Estimate SE 95% CI
↵1 2.311 0.207 (1.904, 2.717)
↵2 4.713 0.520 (3.695, 5.732)
↵3 1.884 0.354 (1.190, 2.578)
 1 1.099 0.240 (0.629, 1.569)
 2 0.629 0.096 (0.441, 0.817)
worse dysphagia.  1 captures the relationship between treatment and dysphagia.
Results suggest that after accounting for T-stage, having induction chemotherapy
is associated with worse dysphagia. In other words, the more aggressive treatment
does seem to be related to more swallowing difficulty. Similarly,  2 looks at the
relationship between T-stage and dysphagia. After accounting for treatment, a
higher T-stage is associated with worse dysphagia. When the same model is fit
assuming a square root link for time on the feeding tube, all of the parameters
remain significant so we would draw the same conclusions. In addition, the  
parameter estimates are very close for both models, suggesting that the results are
robust to the particular link in this setting.
In selecting a final model, we utilized residual plots to consider model fit.
The semiparametric analysis from Chapter 2 produced transformation estimates
that suggested a log or square root link might be reasonable for the time on the
feeding tube and that the identity link would reasonable for weight loss. For the
time on the feeding tube, we fit both models assuming a log link and assuming
a square root link. Residual plots suggested that the log link was a better fit, al-
though as noted above this choice did not influence the   parameter estimates
much. Residual plots were also used to assess model fit in general. For example,
consider the residuals for time on the feeding tube from the model only including
treatment (Figure 3.6). There is a clear departure from normality, suggesting that
the model with treatment only does not fit very well. The residuals for weight loss
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Figure 3.6: Plot looking at the normality of the residuals for time on the feeding tube with
only treatment included in the model.
also demonstrated departure from normality, although the departure was not quite
as extreme. Residuals for the model including both treatment and T-stage can be
seen in Figures 3.7 and 3.8. From Figure 3.7 we see that there is huge improvement
in the model fit with the addition of T-stage. The density and Q-Q plots for both
of the continuous measurable outcomes suggest a pretty good fit. In particular, we
do not see a pattern in these residuals that would suggest that the link function is
incorrectly specified. Figure 3.8, however, does show a clear pattern in the Resid-
uals vs. Fitted plots. This suggests that there is likely a covariate missing from the
analysis. However, due to the small sample size and limited covariates available
for analysis, this is still the best fitting model.
The Swallowing Performance Scale (SPS) score as determined from a video
swallow study is another measure sometimes used to capture dysphagia. Ideally,
we would have the SPS score at baseline for all of the patients in the study so that
SPS score could have been used as an additional measurable outcome. However,
this information was not available due to the retrospective nature of the study. We
do have SPS score information for 48 patients (though the timing of the measure is
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Figure 3.7: Plots looking at the normality of the residuals for model including both treat-
ment and T-stage.
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Figure 3.8: Plots of residuals vs. fitted values for model including both treatment and
T-stage.
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all over the map). As an additional check of our model, we could look at the cor-
relation between the predicted latent variables (in this case ZTi  ˆ) and the SPS score
for the subset of patients with an SPS score. If our latent variable is really captur-
ing dysphagia we would expect there to be a positive correlation, as a higher SPS
score means worse dysphagia. We found the correlation to be 0.40. This suggests
that our latent variable is at least doing a reasonable job of capturing dysphagia.
3.7 Discussion
The latent variable transformationmodel that we have proposed for theHNC anal-
ysis is a useful approach for the DFCI data in particular, but also as a general latent
variable method. Specifically, the model we have proposed has the advantage of
being able to incorporate event times subject to censoring, continuous outcomes,
and discrete outcomes (binary, ordinal, or count) as measurable outcomes in a la-
tent variable framework. In this way, we have covered all potential outcome types
except for nominal outcomes. While youmust pre-specify link functions in this ap-
proach, we have suggested the use of the semiparametric methodology proposed
in Chapter 2 to inform a parametric model and have demonstrated the use of resid-
uals to diagnose incorrect transformation functions. The performance of the latent
variable transformation model is quite good, even when you have a fairly small
sample size, unless you have substantial model misspecification.
In exploring dysphagia, specifically, we are limited by the small sample size
and retrospective design of the DFCI study. The small sample size is a general con-
cern because of the number of parameters that must be estimated using this latent
variable transformation approach. Not only do the ↵,  , and   parameters have to
be estimated, but so do the transformed thresholds and standard deviation param-
eters. When the models can be fit using maximum likelihood, the performance is
pretty good, even with a sample as small as 75 as in the DFCI data. However, we
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are limited by the sample size in the number of covariates that can be included.
Also, there are instances when models of interest simply cannot be fit because the
maximum likelihood procedure fails.
In exploring the DFCI data, we did run into models that simply could not
be fit and/or covariates that could not be included because of too few people in
each category. For example, DFCI investigators were interested in whether type of
radiation is related to dysphagia. However, there were just not enough patients in
each of the different radiation categories to be able to consider this variable in the
model. Also, the model including sex as the X covariate and treatment as the Z
covariate is an example of a model that could not be fit due to a failed maximum
likelihood procedure. Because the study was retrospective, we also did not have
the advantage of the treatment assignment being randomized and were missing
covariates such as smoking status and alcohol use that may be particularly relevant
to head and neck data.
Despite these limitations, we were able to use a small data set to learn some-
thing about dysphagia through the latent variable approach. Receiving induction
chemotherapy in addition to chemoRT appears to be associated with worse dys-
phagia as does a higher T-stage. Also, we have proposed a solid methodological
approach that can be useful in other settings and could be used to further investi-
gate dysphagia once more data is collected.
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